Abstract
This chapter discusses the pathology, epidemiology, associated conditions, and natural history of intracranial aneurysms. Subarachnoid hemorrhage and its management are discussed. Clinical aspects and management strategies for ruptured and unruptured aneurysms including consideration based on aneurysm location is discussed in detail.
This is a preview of subscription content, log in via an institution to check access.
References
Chalouhi N, Hoh BL, Hasan D. Review of cerebral aneurysm formation, growth, and rupture. Stroke. 2013;44:3613–22.
Wang Z, Kolega J, Hoi Y, et al. Molecular alterations associated with aneurysmal remodeling are localized in the high hemodynamic stress region of a created carotid bifurcation. Neurosurgery. 2009;65:169–77; discussion 77–8.
Kadirvel R, Ding YH, Dai D, et al. The influence of hemodynamic forces on biomarkers in the walls of elastase-induced aneurysms in rabbits. Neuroradiology. 2007;49:1041–53.
Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol. 1994;53:399–406.
Sakaki T, Kohmura E, Kishiguchi T, Yuguchi T, Yamashita T, Hayakawa T. Loss and apoptosis of smooth muscle cells in intracranial aneurysms. Studies with in situ DNA end labeling and antibody against single-stranded DNA. Acta Neurochir. 1997;139:469–74; discussion 74–5.
Ali MS, Starke RM, Jabbour PM, et al. TNF-alpha induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab. 2013;33:1564–73.
Chalouhi N, Ali MS, Jabbour PM, et al. Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab. 2012;32:1659–76.
Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke. 2007;38:162–9.
Frösen J, Piippo A, Paetau A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke. 2004;35:2287–93.
Gounis MJ, Vedantham S, Weaver JP, et al. Myeloperoxidase in human intracranial aneurysms: preliminary evidence. Stroke. 2014;45:1474–7.
Etminan N, Dreier R, Buchholz BA, et al. Age of collagen in intracranial saccular aneurysms. Stroke. 2014;45:1757–63.
Tromp G, Weinsheimer S, Ronkainen A, Kuivaniemi H. Molecular basis and genetic predisposition to intracranial aneurysm. Ann Med. 2014;46:597–606.
Hasan DM, Chalouhi N, Jabbour P, et al. Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results. J Am Heart Assoc. 2013;2:e000019.
Starke RM, Chalouhi N, Ding D, Hasan DM. Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis. 2015;39:332–42.
Hasan D, Chalouhi N, Jabbour P, et al. Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. Stroke. 2012;43:3258–65.
Hademenos GJ, Massoud TF, Turjman F, Sayre JW. Anatomical and morphological factors correlating with rupture of intracranial aneurysms in patients referred for endovascular treatment. Neuroradiology. 1998;40:755–60.
Crompton MR. Mechanism of growth and rupture in cerebral berry aneurysms. Br Med J. 1966;5496:1138–42.
Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention. International study of Unruptured intracranial aneurysms investigators. N Engl J Med. 1998;339:1725–33.
Qureshi AI, Suarez JI, Parekh PD, et al. Risk factors for multiple intracranial aneurysms. Neurosurgery. 1998;43:22–6; discussion 6–7.
Juvela S. Risk factors for multiple intracranial aneurysms. Stroke. 2000;31:392–7.
Kaminogo M, Yonekura M, Shibata S. Incidence and outcome of multiple intracranial aneurysms in a defined population. Stroke. 2003;34:16–21.
Ellamushi HE, Grieve JP, Jager HR, Kitchen ND. Risk factors for the formation of multiple intracranial aneurysms. J Neurosurg. 2001;94:728–32.
Marshman LA, Ward PJ, Walter PH, Dossetor RS. The progression of an infundibulum to aneurysm formation and rupture: case report and literature review. Neurosurgery. 1998;43:1445–8. discussion 8–9
Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10:626–36.
Rinkel GJE, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29:251–6.
Chan DY, Abrigo JM, Cheung TC, et al. Screening for intracranial aneurysms? Prevalence of unruptured intracranial aneurysms in Hong Kong Chinese. J Neurosurg. 2016;124:1245–9.
Gabriel RABS, Kim HP, Sidney SMDMPH, et al. Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 2010;41:21–6.
Qureshi AI, Suri MF, Kim SH, et al. Effect of endovascular treatment on headaches in patients with unruptured intracranial aneurysms. Headache. 2003;43:1090–6.
Kong DS, Hong SC, Jung YJ, Kim JS. Improvement of chronic headache after treatment of unruptured intracranial aneurysms. Headache. 2007;47:693–7.
Raps EC, Rogers JD, Galetta SL, et al. The clinical spectrum of unruptured intracranial aneurysms. Arch Neurol. 1993;50:265–8.
Choxi AABE, Durrani AKBE, Mericle RAMD. Both surgical clipping and endovascular embolization of unruptured intracranial aneurysms are associated with long-term improvement in self-reported quantitative headache scores. Neurosurgery. 2011;69:128–34.
Lozano AM, Leblanc R. Familial intracranial aneurysms. J Neurosurg. 1987;66:522–8.
Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intracranial aneurysms. Lancet. 1997;349:380–4.
Schievink WI, Schaid DJ, Michels VV, Piepgras DG. Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg. 1995;83:426–9.
Schievink WI, Schaid DJ, Rogers HM, Piepgras DG, Michels VV. On the inheritance of intracranial aneurysms. Stroke. 1994;25:2028–37.
Bromberg JE, Rinkel GJ, Algra A, et al. Familial subarachnoid hemorrhage: distinctive features and patterns of inheritance. Ann Neurol. 1995;38:929–34.
Ruigrok YM, Rinkel GJE, Algra A, Raaymakers TWM, van Gijn J. Characteristics of intracranial aneurysms in patients with familial subarachnoid hemorrhage. Neurology. 2004;62:891–4.
Bromberg JE, Rinkel GJ, Algra A, Limburg M, van Gijn J. Outcome in familial subarachnoid hemorrhage. Stroke. 1995;26:961–3.
Yamada S, Utsunomiya M, Inoue K, et al. Genome-wide scan for japanese familial intracranial aneurysms: linkage to several chromosomal regions. Circulation. 2004;110:3727–33.
Ruigrok YM, Seitz U, Wolterink S, Rinkel GJE, Wijmenga C, Urban Z. Association of polymorphisms and haplotypes in the elastin gene in dutch patients with sporadic aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:2064–8.
Schievink WI. Genetics of intracranial aneurysms. Neurosurgery. 1997;40:651–62; discussion 62–3.
Korja MMDP, Silventoinen KP, McCarron PMDP, et al. Genetic epidemiology of spontaneous subarachnoid hemorrhage: nordic twin study. Stroke. 2010;41:2458–62.
Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the stroke council of the american heart association. Stroke. 2000;31:2742–50.
Ronkainen A, Puranen MI, Hernesniemi JA, et al. Intracranial aneurysms: MR angiographic screening in 400 asymptomatic individuals with increased familial risk. Radiology. 1995;195:35–40.
Raaymakers TW, Rinkel GJ, Ramos LM. Initial and follow-up screening for aneurysms in families with familial subarachnoid hemorrhage. Neurology. 1998;51:1125–30.
Broderick JP, Sauerbeck LR, Foroud T, et al. The familial intracranial aneurysm (FIA) study protocol. BMC Med Genet. 2005;6:17.
Hughes J, Ward CJ, Peral B, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet. 1995;10:151–60.
Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272:1339–42.
Arnaout MA. The vasculopathy of autosomal dominant polycystic kidney disease: insights from animal models. Kidney Int. 2000;58:2599–610.
Badani KK, Hemal AK, Menon M. Autosomal dominant polycystic kidney disease and pain—a review of the disease from aetiology, evaluation, past surgical treatment options to current practice. J Postgrad Med. 2004;50:222–6.
Chapman AB, Johnson AM, Gabow PA. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen. Am J Kidney Dis. 1993;22:526–31.
Bobrie G, Brunet-Bourgin F, Alamowitch S, et al. Spontaneous artery dissection: is it part of the spectrum of autosomal dominant polycystic kidney disease? Nephrol Dial Transplant. 1998;13:2138–41.
Schievink WI, Torres VE, Wiebers DO, Huston J 3rd. Intracranial arterial dolichoectasia in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1997;8:1298–303.
Schievink WI, Huston J 3rd, Torres VE, Marsh WR. Intracranial cysts in autosomal dominant polycystic kidney disease. J Neurosurg. 1995;83:1004–7.
Schievink WI, Torres VE. Spinal meningeal diverticula in autosomal dominant polycystic kidney disease. Lancet. 1997;349:1223–4.
Widjicks EFM. Aneurysmal subarachnoid hemorrhage. The clinical practice of critical care neurology. 2nd ed. Oxford, UK: Oxford University Press; 2003. p. 185–220.
Fehlings MG, Gentili F. The association between polycystic kidney disease and cerebral aneurysms. Can J Neurol Sci. 1991;18:505–9.
Xu HWMDP, Yu SQMDP, Mei CLP, Li MHMDP. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke. 2011;42:204–6.
Schievink WI, Torres VE, Piepgras DG, Wiebers DO. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1992;3:88–95.
Schievink WI. Intracranial aneurysms. N Engl J Med. 1997;336:28–40.
Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2002;13:269–76.
Chauveau D, Pirson Y, Verellen-Dumoulin C, Macnicol A, Gonzalo A, Grunfeld JP. Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int. 1994;45:1140–6.
Belz MM, Fick-Brosnahan GM, Hughes RL, et al. Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int. 2003;63:1824–30.
Schrier RW, Belz MM, Johnson AM, et al. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up. J Am Soc Nephrol. 2004;15:1023–8.
Byers PH. Ehlers-Danlos syndrome type IV: a genetic disorder in many guises. J Invest Dermatol. 1995;105:311–3.
Jung SC, Kim CH, Ahn JH, et al. Endovascular treatment of intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. Neurosurgery. 2016;78:429–35; discussion 35.
Germain DP. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2002;16:391–7.
Mitsuhashi T, Miyajima M, Saitoh R, Nakao Y, Hishii M, Arai H. Spontaneous carotid-cavernous fistula in a patient with Ehlers-Danlos syndrome type IV—case report. Neurol Med Chir (Tokyo). 2004;44:548–53.
Freeman RK, Swegle J, Sise MJ. The surgical complications of Ehlers-Danlos syndrome. Am Surg. 1996;62:869–73.
DeMeo DL, Silverman EK. {alpha}1-antitrypsin deficiency {middle dot} 2: genetic aspects of {alpha}1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax. 2004;59:259–64.
Schievink WI, Katzmann JA, Piepgras DG, Schaid DJ. Alpha-1-antitrypsin phenotypes among patients with intracranial aneurysms. J Neurosurg. 1996;84:781–4.
Kissela BM, Sauerbeck L, Woo D, et al. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke. 2002;33:1321–6.
Yoneyama T, Kasuya H, Akagawa H, et al. Absence of alpha-1 antitrypsin deficiency alleles (S and Z) in Japanese and Korean patients with aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:e376–8.
Schievink WI. Genetics of intracranial aneurysms. In: Winn HR, editor. Youmans neurological surgery. 5th ed. Philadelphia: Saunders; 2004. p. 1769–79.
Conway JE, Hutchins GM, Tamargo RJ. Marfan syndrome is not associated with intracranial aneurysms. Stroke. 1999;30:1632–6.
Iqbal A, Alter M, Lee SH. Pseudoxanthoma elasticum: a review of neurological complications. Ann Neurol. 1978;4:18–20.
Munyer TP, Margulis AR. Pseudoxanthoma elasticum with internal carotid artery aneurysm. AJR Am J Roentgenol. 1981;136:1023–4.
van den Berg JS, Hennekam RC, Cruysberg JR, et al. Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in pseudoxanthoma elasticum. Cerebrovasc Dis. 2000;10:315–9.
Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37:275–81.
Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788–98.
Rodrigues VJ, Elsayed S, Loeys BL, Dietz HC, Yousem DM. Neuroradiologic manifestations of Loeys-Dietz syndrome type 1. AJNR Am J Neuroradiol. 2009;30:1614–9.
Van Den Berg DJ, Francke U. Roberts syndrome: a review of 100 cases and a new rating system for severity. Am J Med Genet. 1993;47:1104–23.
Vega H, Waisfisz Q, Gordillo M, et al. Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion. Nat Genet. 2005;37:468–70.
Robers JB. A child with double cleft of lip and palate, protrusion of the intermaxillary portion of the upper jaw and imperfect development of the bones of the four extremities. Ann Surg. 1919;70:252–3.
Wang AC, Gemmete JJ, Keegan CE, et al. Spontaneous intracranial hemorrhage and multiple intracranial aneurysms in a patient with Roberts/SC phocomelia syndrome. J Neurosurg Pediatr. 2011;8:460–3.
Stapf C, Mohr JP, Pile-Spellman J, et al. Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation. J Neurol Neurosurg Psychiatry. 2002;73:294–8.
Redekop G, TerBrugge K, Montanera W, Willinsky R. Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg. 1998;89:539–46.
Meisel HJ, Mansmann U, Alvarez H, Rodesch G, Brock M, Lasjaunias P. Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients. Neurosurgery. 2000;46:793–800; discussion -2.
Mansmann U, Meisel J, Brock M, Rodesch G, Alvarez H, Lasjaunias P. Factors associated with intracranial hemorrhage in cases of cerebral arteriovenous malformation. Neurosurgery. 2000;46:272–9; discussion 9–81.
Orning J, Amin-Hanjani S, Hamade Y, et al. Increased prevalence and rupture status of feeder vessel aneurysms in posterior fossa arteriovenous malformations. J Neurointerv Surg. 2016;8:1021–4.
Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg. 1998;88:436–40.
Norrgard O, Angqvist KA, Fodstad H, Forssell A, Lindberg M. Co-existence of abdominal aortic aneurysms and intracranial aneurysms. Acta Neurochir. 1987;87:34–9.
Kanai H, Umezu M, Koide K, Hato M. Ruptured intracranial aneurysm associated with unruptured abdominal aortic aneurysm—case report. Neurol Med Chir (Tokyo). 2001;41:260–3.
Preul MC, Cendes F, Just N, Mohr G. Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery. 1998;42:971–7; discussion 7–8.
Birkeland P, Gardner K, Kesse-Adu R, et al. Intracranial aneurysms in sickle-cell disease are associated with the hemoglobin SS genotype but not with moyamoya syndrome. Stroke. 2016;47:1710–3.
Schievink WI, Maya MM. Frequency of intracranial aneurysms in patients with spontaneous intracranial hypotension. J Neurosurg. 2011;115:113–5.
Schievink WI, Raissi SS, Maya MM, Velebir A. Screening for intracranial aneurysms in patients with bicuspid aortic valve. Neurology. 2010;74:1430–3.
Backes D, Vergouwen MD, Tiel Groenestege AT, et al. PHASES score for prediction of intracranial aneurysm growth. Stroke. 2015;46:1221–6.
Greving JP, Wermer MJ, Brown RD Jr, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol. 2014;13:59–66.
Kang HG, Kim BJ, Lee J, et al. Risk factors associated with the presence of unruptured intracranial aneurysms. Stroke. 2015;46:3093–8.
Backes D, Rinkel GJ, Laban KG, Algra A, Vergouwen MD. Patient- and aneurysm-specific risk factors for intracranial aneurysm growth: a systematic review and meta-analysis. Stroke. 2016;47:951–7.
Chien A, Liang F, Sayre J, Salamon N, Villablanca P, Vinuela F. Enlargement of small, asymptomatic, unruptured intracranial aneurysms in patients with no history of subarachnoid hemorrhage: the different factors related to the growth of single and multiple aneurysms. J Neurosurg. 2013;119:190–7.
Chyatte D, Chen TL, Bronstein K, Brass LM. Seasonal fluctuation in the incidence of intracranial aneurysm rupture and its relationship to changing climatic conditions. J Neurosurg. 1994;81:525–30.
Inagawa T, Takechi A, Yahara K, et al. Primary intracerebral and aneurysmal subarachnoid hemorrhage in Izumo City, Japan. Part I: incidence and seasonal and diurnal variations. J Neurosurg. 2000;93:958–66.
Abe T, Ohde S, Ishimatsu S, et al. Effects of meteorological factors on the onset of subarachnoid hemorrhage: a time-series analysis. J Clin Neurosci. 2008;15:1005–10.
Buxton N, Liu C, Dasic D, Moody P, Hope DT. Relationship of aneurysmal subarachnoid hemorrhage to changes in atmospheric pressure: results of a prospective study. J Neurosurg. 2001;95:391–2.
Beseoglu K, Hanggi D, Stummer W, Steiger HJ. Dependence of subarachnoid hemorrhage on climate conditions: a systematic meteorological analysis from the Dusseldorf metropolitan area. Neurosurgery. 2008;62:1033–8; discussion 8–9.
Cowperthwaite MCP, Burnett MGMD. The association between weather and spontaneous subarachnoid hemorrhage: an analysis of 155 US hospitals. Neurosurgery. 2011;68:132–9.
Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103–10.
Morita A, Kirino T, Hashi K, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012;366:2474–82.
Sonobe M, Yamazaki T, Yonekura M, Kikuchi H. Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. Stroke. 2010;41:1969–77.
Bor AS, Tiel Groenestege AT, terBrugge KG, et al. Clinical, radiological, and flow-related risk factors for growth of untreated, unruptured intracranial aneurysms. Stroke. 2015;46:42–8.
Kashiwazaki D, Kuroda S, Sapporo SAHSG. Size ratio can highly predict rupture risk in intracranial small (<5 mm) aneurysms. Stroke. 2013;44:2169–73.
Lindgren AE, Koivisto T, Bjorkman J, et al. Irregular shape of intracranial aneurysm indicates rupture risk irrespective of size in a population-based cohort. Stroke. 2016;47:1219–26.
Backes D, Vergouwen MD, Velthuis BK, et al. Difference in aneurysm characteristics between ruptured and unruptured aneurysms in patients with multiple intracranial aneurysms. Stroke. 2014;45:1299–303.
Lin N, Ho A, Gross BA, et al. Differences in simple morphological variables in ruptured and unruptured middle cerebral artery aneurysms. J Neurosurg. 2012;117:913–9.
Juvela S, Poussa K, Lehto H, Porras M. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. Stroke. 2013;44:2414–21.
Kaspera W, Ladzinski P, Larysz P, et al. Morphological, hemodynamic, and clinical independent risk factors for anterior communicating artery aneurysms. Stroke. 2014;45:2906–11.
Wermer MJ, van der Schaaf IC, Algra A, Rinkel GJ. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke. 2007;38:1404–10.
Feigin VL, Rinkel GJE, Lawes CMM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36:2773–80.
Baker CJ, Fiore A, Connolly ES Jr, Baker KZ, Solomon RA. Serum elastase and alpha-1-antitrypsin levels in patients with ruptured and unruptured cerebral aneurysms. Neurosurgery. 1995;37:56–61; discussion -2.
Gaetani P, Tartara F, Tancioni F, Klersy C, Forlino A, Baena RR. Activity of alpha 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm. J Neurol Sci. 1996;141:33–8.
Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke. 2001;32:485–91.
Morris KM, Shaw MD, Foy PM. Smoking and subarachnoid haemorrhage: a case control study. Br J Neurosurg. 1992;6:429–32.
Canhao P, Pinto AN, Ferro H, Ferro JM. Smoking and aneurysmal subarachnoid haemorrhage: a case-control study. J Cardiovasc Risk. 1994;1:155–8.
Wermer MJH, Greebe P, Algra A, Rinkel GJE. Incidence of recurrent subarachnoid hemorrhage after clipping for ruptured intracranial aneurysms. Stroke. 2005;36:2394–9.
Lasner TM, Weil RJ, Riina HA, et al. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997;87:381–4.
Weir BK, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest A. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the cooperative aneurysm study. J Neurosurg. 1998;89:405–11.
Ortiz R, Stefanski M, Rosenwasser R, Veznedaroglu E. Cigarette smoking as a risk factor for recurrence of aneurysms treated by endosaccular occlusion. J Neurosurg. 2008;108:672–5.
Veznedaroglu E, Koebbe CJ, Siddiqui A, Rosenwasser RH. Initial experience with bioactive cerecyte detachable coils: impact on reducing recurrence rates. Neurosurgery. 2008;62:799–805; discussion -6.
Brinjikji W, Lingineni RK, Gu CN, et al. Smoking is not associated with recurrence and retreatment of intracranial aneurysms after endovascular coiling. J Neurosurg. 2015;122:95–100.
Isaksen J, Egge A, Waterloo K, Romner B, Ingebrigtsen T. Risk factors for aneurysmal subarachnoid haemorrhage: the Tromso study. J Neurol Neurosurg Psychiatry. 2002;73:185–7.
Rinkel GJ. Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol. 2005;4:122–8.
Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993;24:639–46.
Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke. 1992;23(9):1242.
Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to alcohol consumption: a prospective study among male British doctors. Int J Epidemiol. 2005;34:199–204.
Johnston SC, Colford JM Jr, Gress DR. Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis. Neurology. 1998;51:411–8.
Teunissen LL, Rinkel GJ, Algra A, van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke. 1996;27:544–9.
Adamson J, Humphries SE, Ostergaard JR, Voldby B, Richards P, Powell JT. Are cerebral aneurysms atherosclerotic? Stroke. 1994;25:963–6.
Phan K, Moore JM, Griessenauer CJ, Ogilvy CS, Thomas AJ. Aspirin and risk of subarachnoid hemorrhage: systematic review and meta-analysis. Stroke. 2017;48:1210–7.
Ferro JM, Pinto AN. Sexual activity is a common precipitant of subarachnoid hemorrhage. Cerebrovasc Dis. 1994;4:375.
Reynolds MR, Willie JT, Zipfel GJ, Dacey RG. Sexual intercourse and cerebral aneurysmal rupture: potential mechanisms and precipitants. J Neurosurg. 2011;114:969–77.
International study of Unruptured intracranial aneurysms I. Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention. N Engl J Med. 1998;339:1725–33.
Association AH. Heart disease and stroke statistics—2005 update. American Heart Association: Dallas; 2005.
Wiebers DO, Whisnant JP, Sundt TM Jr, O'Fallon WM. The significance of unruptured intracranial saccular aneurysms. J Neurosurg. 1987;66:23–9.
Forget TR Jr, Benitez R, Veznedaroglu E, et al. A review of size and location of ruptured intracranial aneurysms. Neurosurgery. 2001;49:1322–5; discussion 5–6.
Beck J, Rohde S, Berkefeld J, Seifert V, Raabe A. Size and location of ruptured and unruptured intracranial aneurysms measured by 3-dimensional rotational angiography. Surg Neurol. 2006;65:18–25; discussion -7.
Rahman MMD, Ogilvy CSMD, Zipfel GJMD, et al. Unruptured cerebral aneurysms do not shrink when they rupture: multicenter collaborative aneurysm study group. Neurosurgery. 2011;68:155–61.
Skodvin TO, Johnsen LH, Gjertsen O, Isaksen JG, Sorteberg A. Cerebral aneurysm morphology before and after rupture: nationwide case series of 29 aneurysms. Stroke. 2017;48:880–6.
Jeong YG, Jung YT, Kim MS, Eun CK, Jang SH. Size and location of ruptured intracranial aneurysms. J Korean Neurosurg Soc. 2009;45:11–5.
Alshekhlee A, Mehta S, Edgell RC, et al. Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm. Stroke. 2010;41:1471–6.
Inoue T, Shimizu H, Fujimura M, Saito A, Tominaga T. Annual rupture risk of growing unruptured cerebral aneurysms detected by magnetic resonance angiography. J Neurosurg. 2012;117:20–5.
Serrone JC, Tackla RD, Gozal YM, et al. Aneurysm growth and de novo aneurysms during aneurysm surveillance. J Neurosurg. 2016;125:1374–82.
Lindgren AE, Raisanen S, Bjorkman J, et al. De novo aneurysm formation in carriers of saccular intracranial aneurysm disease in eastern Finland. Stroke. 2016;47:1213–8.
Wang JY, Smith R, Ye X, et al. Serial imaging surveillance for patients with a history of intracranial aneurysm: risk of de novo aneurysm formation. Neurosurgery. 2015;77:32–42; discussion -3.
Buijs JE, Greebe P, Rinkel GJ. Quality of life, anxiety, and depression in patients with an unruptured intracranial aneurysm with or without aneurysm occlusion. Neurosurgery. 2012;70:868–72.
Yamashiro S, Nishi T, Koga K, et al. Improvement of quality of life in patients surgically treated for asymptomatic unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry. 2007;78:497–500.
Yoshimoto Y. Publication bias in neurosurgery: lessons from series of unruptured aneurysms. Acta Neurochir. 2003;145:45–8.
Macdonald RL, Wallace MC, Kestle JR. Role of angiography following aneurysm surgery. J Neurosurg. 1993;79:826–32.
Thornton J, Bashir Q, Aletich VA, Debrun GM, Ausman JI, Charbel FT. What percentage of surgically clipped intracranial aneurysms have residual necks? Neurosurgery. 2000;46:1294–8; discussion 8–300.
Sindou M, Acevedo JC, Turjman F. Aneurysmal remnants after microsurgical clipping: classification and results from a prospective angiographic study (in a consecutive series of 305 operated intracranial aneurysms). Acta Neurochir. 1998;140:1153–9.
Feuerberg I, Lindquist C, Lindqvist M, Steiner L. Natural history of postoperative aneurysm rests. J Neurosurg. 1987;66:30–4.
David CA, Vishteh AG, Spetzler RF, Lemole M, Lawton MT, Partovi S. Late angiographic follow-up review of surgically treated aneurysms. J Neurosurg. 1999;91:396–401.
Tsutsumi K, Ueki K, Usui M, Kwak S, Kirino T. Risk of recurrent subarachnoid hemorrhage after complete obliteration of cerebral aneurysms. Stroke. 1998;29:2511–3.
The CI. Rates of delayed rebleeding from intracranial aneurysms are low after surgical and endovascular treatment. Stroke. 2006;37:1437–42.
Raaymakers TW, Rinkel GJ, Limburg M, Algra A. Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke. 1998;29(8):1531.
Johnston SC, Zhao S, Dudley RA, Berman MF, Gress DR. Treatment of unruptured cerebral aneurysms in California. Stroke. 2001;32:597–605.
Ogilvy CS, Carter BS. Stratification of outcome for surgically treated unruptured intracranial aneurysms. Neurosurgery. 2003;52:82–7; discussion 7–8.
O'Donnell JM, Morgan MK, Bervini D, Heller GZ, Assaad N. The risk of seizure after surgery for unruptured intracranial aneurysms: a prospective cohort study. Neurosurgery. 2016;79:222–30.
Inoue T, Ohwaki K, Tamura A, Tsutsumi K, Saito I, Saito N. Subtle structural change demonstrated on T2-weighted images after clipping of unruptured intracranial aneurysm: negative effects on cognitive performance. J Neurosurg. 2014;120:937–44.
Ronkainen A, Niskanen M, Rinne J, Koivisto T, Hernesniemi J, Vapalahti M. Evidence for excess long-term mortality after treated subarachnoid hemorrhage. Stroke. 2001;32:2850–3.
Britz GW, Salem L, Newell DW, Eskridge J, Flum DR. Impact of surgical clipping on survival in unruptured and ruptured cerebral aneurysms: a population-based study. Stroke. 2004;35:1399–403.
Rodriguez-Hernandez A, Gabarros A, Lawton MT. Contralateral clipping of middle cerebral artery aneurysms: rationale, indications, and surgical technique. Neurosurgery. 2012;71:116–23; discussion 23–4.
Raftopoulos C, Mathurin P, Boscherini D, Billa RF, Van Boven M, Hantson P. Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first option. J Neurosurg. 2000;93:175–82.
Ng P, Khangure MS, Phatouros CC, Bynevelt M, ApSimon H, McAuliffe W. Endovascular treatment of intracranial aneurysms with guglielmi detachable coils: analysis of midterm angiographic and clinical outcomes. Stroke. 2002;33:210–7.
Murayama Y, Nien YL, Duckwiler G, et al. Guglielmi detachable coil embolization of cerebral aneurysms: 11 years’ experience. J Neurosurg. 2003;98:959–66.
Gonzalez N, Murayama Y, Nien YL, et al. Treatment of unruptured aneurysms with GDCs: clinical experience with 247 aneurysms. AJNR Am J Neuroradiol. 2004;25:577–83.
Pouratian N, Oskouian RJ Jr, Jensen ME, Kassell NF, Dumont AS. Endovascular management of unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry. 2006;77:572–8.
Goddard AJ, Annesley-Williams D, Gholkar A. Endovascular management of unruptured intracranial aneurysms: does outcome justify treatment? J Neurol Neurosurg Psychiatry. 2002;72:485–90.
Brilstra EH, Rinkel GJ, van der Graaf Y, van Rooij WJ, Algra A. Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke. 1999;30:470–6.
Raymond J, Guilbert F, Weill A, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke. 2003;34:1398–403.
Gallas S, Pasco A, Cottier J-P, et al. A multicenter study of 705 ruptured intracranial aneurysms treated with guglielmi detachable coils. AJNR Am J Neuroradiol. 2005;26:1723–31.
Li MH, Gao BL, Fang C, et al. Angiographic follow-up of cerebral aneurysms treated with guglielmi detachable coils: an analysis of 162 cases with 173 aneurysms. AJNR Am J Neuroradiol. 2006;27:1107–12.
Iijima A, Piotin M, Mounayer C, Spelle L, Weill A, Moret J. Endovascular treatment with coils of 149 middle cerebral artery berry aneurysms. Radiology. 2005;237:611–9.
Ferns SPMD, Sprengers MESMDP, van Rooij WJMDP, et al. Late reopening of adequately coiled intracranial aneurysms: frequency and risk factors in 400 patients with 440 aneurysms. Stroke. 2011;42:1331–7.
Tamatani S, Ito Y, Abe H, Koike T, Takeuchi S, Tanaka R. Evaluation of the stability of aneurysms after embolization using detachable coils: correlation between stability of aneurysms and embolized volume of aneurysms. AJNR Am J Neuroradiol. 2002;23:762–7.
Szikora I, Wakhloo AK, Guterman LR, et al. Initial experience with collagen-filled Guglielmi detachable coils for endovascular treatment of experimental aneurysms. AJNR Am J Neuroradiol. 1997;18:667–72.
Zaroff JG, Rordorf GA, Newell JB, Ogilvy CS, Levinson JR. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery. 1999;44:34–9; discussion 9–40.
Soeda A, Sakai N, Sakai H, Iihara K, Nagata I. Endovascular treatment of asymptomatic cerebral aneurysms: anatomic and technical factors related to ischemic events and coil stabilization. Neurol Med Chir (Tokyo). 2004;44:456–65; discussion 66.
Piotin MMDP, Blanc RMDM, Spelle LMDP, et al. Stent-assisted coiling of intracranial aneurysms: clinical and angiographic results in 216 consecutive aneurysms. Stroke. 2010;41:110–5.
Brinjikji WBS, Lanzino GMD, Cloft HJMDP, Rabinstein AMD, Kallmes DFMD. Endovascular treatment of very small (3 mm or smaller) intracranial aneurysms: report of a consecutive series and a meta-analysis. Stroke. 2010;41:116–21.
Friedman JA, Nichols DA, Meyer FB, et al. Guglielmi detachable coil treatment of ruptured saccular cerebral aneurysms: retrospective review of a 10-year single-center experience. AJNR Am J Neuroradiol. 2003;24:526–33.
Lempert TE, Malek AM, Halbach VV, et al. Endovascular treatment of ruptured posterior circulation cerebral aneurysms. Clinical and angiographic outcomes. Stroke. 2000;31:100–10.
Plowman RS, Clarke A, Clarke M, Byrne JV. Sixteen-year single-surgeon experience with coil embolization for ruptured intracranial aneurysms: recurrence rates and incidence of late rebleeding. J Neurosurg. 2011;114:863–74.
Fleming JB, Hoh BL, Simon SD, et al. Rebleeding risk after treatment of ruptured intracranial aneurysms. J Neurosurg. 2011;114:1778–84.
Byrne JV, Sohn MJ, Molyneux AJ, Chir B. Five-year experience in using coil embolization for ruptured intracranial aneurysms: outcomes and incidence of late rebleeding. J Neurosurg. 1999;90:656–63.
Uda K, Goto K, Ogata N, Izumi N, Nagata S, Matsuno H. Embolization of cerebral aneurysms using Guglielmi detachable coils—problems and treatment plans in the acute stage after subarachnoid hemorrhage and long-term efficiency. Neurol Med Chir (Tokyo). 1998;38:143–52; discussion 52–4.
Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809–17.
Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–74.
Lee T, Baytion M, Sciacca R, Mohr JP, Pile-Spellman J. Aggregate analysis of the literature for unruptured intracranial aneurysm treatment. AJNR Am J Neuroradiol. 2005;26:1902–8.
Brinjikji WBS, Rabinstein AAMD, Lanzino GMD, Kallmes DFMD, Cloft HJMDP. Effect of age on outcomes of treatment of unruptured cerebral aneurysms: a study of the national inpatient sample 2001–2008. Stroke. 2011;42:1320–4.
Vanninen R, Koivisto T, Saari T, Hernesniemi J, Vapalahti M. Ruptured intracranial aneurysms: acute endovascular treatment with electrolytically detachable coils—a prospective randomized study. Radiology. 1999;211:325–36.
Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV-034343), a selective endothelin a receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103:9–17.
Dumont ASMD, Crowley RWMD, Monteith SJMD, et al. Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms: effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome. Stroke. 2010;41:2519–24.
Kallmes DF, Ding YH, Dai D, Kadirvel R, Lewis DA, Cloft HJ. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke. 2007;38:2346–52.
Fiorella D, Woo HH, Albuquerque FC, Nelson PK. Definitive reconstruction of circumferential, fusiform intracranial aneurysms with the pipeline embolization device. Neurosurgery. 2008;62:1115–20; discussion 20–1.
Sadasivan C, Cesar L, Seong J, Wakhloo AK, Lieber BB. Treatment of rabbit elastase-induced aneurysm models by flow diverters: development of quantifiable indexes of device performance using digital subtraction angiography. IEEE Trans Med Imaging. 2009;28:1117–25.
Fiorella D, Lylyk P, Szikora I, et al. Curative cerebrovascular reconstruction with the pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms. J NeuroIntervent Surg. 2009;1:56–65.
Aenis M, Stancampiano AP, Wakhloo AK, Lieber BB. Modeling of flow in a straight stented and nonstented side wall aneurysm model. J Biomech Eng. 1997;119:206–12.
Kim YH, Xu X, Lee JS. The effect of stent porosity and strut shape on saccular aneurysm and its numerical analysis with lattice Boltzmann method. Ann Biomed Eng. 2010;38:2274–92.
Kim M, Taulbee DB, Tremmel M, Meng H. Comparison of two stents in modifying cerebral aneurysm hemodynamics. Ann Biomed Eng. 2008;36:726–41.
Meng H, Wang Z, Kim M, Ecker RD, Hopkins LN. Saccular aneurysms on straight and curved vessels are subject to different hemodynamics: implications of intravascular stenting. AJNR Am J Neuroradiol. 2006;27:1861–5.
Wakhloo AK, Tio FO, Lieber BB, Schellhammer F, Graf M, Hopkins LN. Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response. AJNR Am J Neuroradiol. 1995;16:1043–51.
Lopes DK, Ringer AJ, Boulos AS, et al. Fate of branch arteries after intracranial stenting. Neurosurgery. 2003;52:1275–8; discussion 8–9.
Sadasivan C, Cesar L, Seong J, et al. An original flow diversion device for the treatment of intracranial aneurysms: evaluation in the rabbit elastase-induced model. Stroke. 2009;40:952–8.
Brinjikji W, Murad MH, Lanzino G, Cloft HJ, Kallmes DF. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013;44:442–7.
Lubicz B, Collignon L, Raphaeli G, et al. Flow-diverter stent for the endovascular treatment of intracranial aneurysms: a prospective study in 29 patients with 34 aneurysms. Stroke. 2010;41:2247–53.
Byrne JV, Beltechi R, Yarnold JA, Birks J, Kamran M. Early experience in the treatment of intra-cranial aneurysms by endovascular flow diversion: a multicentre prospective study. PLoS One. 2010;5
Kulcsár Z, Ernemann U, Wetzel SG, et al. High-profile flow diverter (silk) implantation in the basilar artery: efficacy in the treatment of aneurysms and the role of the perforators. Stroke. 2010;41:1690–6.
Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, Fiorella D. The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol. 2011;32:34–40.
Lylyk P, Miranda C, Ceratto R, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery. 2009;64:632–42; discussion 42–3; quiz N6.
Szikora I, Berentei Z, Kulcsar Z, et al. Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. AJNR Am J Neuroradiol. 2010;31:1139–47.
Fischer S, Vajda Z, Aguilar Perez M, et al. Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections. Neuroradiology. 2012;54(4):369–82.
Rouchaud A, Brinjikji W, Lanzino G, Cloft HJ, Kadirvel R, Kallmes DF. Delayed hemorrhagic complications after flow diversion for intracranial aneurysms: a literature overview. Neuroradiology. 2016;58:171–7.
Kulcsár Z, Houdart E, Bonafe A, et al. Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol. 2011;32:20–5.
Turowski B, Macht S, Kulcsar Z, Hanggi D, Stummer W. Early fatal hemorrhage after endovascular cerebral aneurysm treatment with a flow diverter (SILK-stent): do we need to rethink our concepts? Neuroradiology. 2011;53:37–41.
Cebral JR, Mut F, Raschi M, et al. Aneurysm rupture following treatment with flow-diverting stents: computational hemodynamics analysis of treatment. AJNR Am J Neuroradiol. 2011;32:27–33.
Cruz JP, Chow M, O'Kelly C, et al. Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms. AJNR Am J Neuroradiol. 2012;33:603–8.
Safar ME, Blacher J, Mourad JJ, London GM. Stiffness of carotid artery wall material and blood pressure in humans: application to antihypertensive therapy and stroke prevention. Stroke. 2000;31:782–90.
Hussein AE, Esfahani DR, Linninger A, et al. Aneurysm size and the Windkessel effect: an analysis of contrast intensity in digital subtraction angiography. Interv Neuroradiol. 2017;23(4):357–61.
Guédon A, Clarencon F, Di Maria F, et al. Very late ischemic complications in flow-diverter stents: a retrospective analysis of a single-center series. J Neurosurg. 2016;125:929–35.
John S, Bain MD, Hui FK, et al. Long-term follow-up of in-stent stenosis after pipeline flow diversion treatment of intracranial aneurysms. Neurosurgery. 2016;78:862–7.
Li MH, Li YD, Gao BL, et al. A new covered stent designed for intracranial vasculature: application in the management of pseudoaneurysms of the cranial internal carotid artery. AJNR Am J Neuroradiol. 2007;28:1579–85.
Li MH, Li YD, Tan HQ, Luo QY, Cheng YS. Treatment of distal internal carotid artery aneurysm with the willis covered stent: a prospective pilot study. Radiology. 2009;253:470–7.
Li MH, Zhu YQ, Fang C, et al. The feasibility and efficacy of treatment with a Willis covered stent in recurrent intracranial aneurysms after coiling. AJNR Am J Neuroradiol. 2008;29:1395–400.
Pumar JM, Blanco M, Vazquez F, Castineira JA, Guimaraens L, Garcia-Allut A. Preliminary experience with leo self-expanding stent for the treatment of intracranial aneurysms. AJNR Am J Neuroradiol. 2005;26:2573–7.
Pumar JM, Lete I, Pardo MI, Vazquez-Herrero F, Blanco M. LEO stent monotherapy for the endovascular reconstruction of fusiform aneurysms of the middle cerebral artery. AJNR Am J Neuroradiol. 2008;29:1775–6.
Solomon RA, Fink ME, Pile-Spellman J. Surgical management of unruptured intracranial aneurysms. J Neurosurg. 1994;80:440–6.
Malisch TW, Guglielmi G, Vinuela F, et al. Unruptured aneurysms presenting with mass effect symptoms: response to endosaccular treatment with Guglielmi detachable coils. Part I. Symptoms of cranial nerve dysfunction. J Neurosurg. 1998;89:956–61.
Yanaka K, Matsumaru Y, Mashiko R, Hyodo A, Sugimoto K, Nose T. Small unruptured cerebral aneurysms presenting with oculomotor nerve palsy. Neurosurgery. 2003;52:553–7; discussion 6–7.
Rodriguez-Catarino M, Frisen L, Wikholm G, Elfverson J, Quiding L, Svendsen P. Internal carotid artery aneurysms, cranial nerve dysfunction and headache: the role of deformation and pulsation. Neuroradiology. 2003;45:236–40.
Halbach VV, Higashida RT, Dowd CF, et al. The efficacy of endosaccular aneurysm occlusion in alleviating neurological deficits produced by mass effect. J Neurosurg. 1994;80:659–66.
Kazekawa K, Tsutsumi M, Aikawa H, et al. Internal carotid aneurysms presenting with mass effect symptoms of cranial nerve dysfunction: efficacy and imitations of endosaccular embolization with GDC. Radiat Med. 2003;21:80–5.
Chen PR, Amin-Hanjani S, Albuquerque FC, McDougall C, Zabramski JM, Spetzler RF. Outcome of oculomotor nerve palsy from posterior communicating artery aneurysms: comparison of clipping and coiling. Neurosurgery. 2006;58:1040–6; discussion -6.
Ahn JY, Han IB, Yoon PH, et al. Clipping vs coiling of posterior communicating artery aneurysms with third nerve palsy. Neurology. 2006;66:121–3.
Tan H, Huang G, Zhang T, Liu J, Li Z, Wang Z. A retrospective comparison of the influence of surgical clipping and endovascular embolization on recovery of oculomotor nerve palsy in patients with posterior communicating artery aneurysms. Neurosurgery. 2015;76:687–94; discussion 94.
McCracken DJ, Lovasik BP, McCracken CE, et al. Resolution of oculomotor nerve palsy secondary to posterior communicating artery aneurysms: comparison of clipping and coiling. Neurosurgery. 2015;77:931–9; discussion 9.
Lv N, Yu Y, Xu J, Karmonik C, Liu J, Huang Q. Hemodynamic and morphological characteristics of unruptured posterior communicating artery aneurysms with oculomotor nerve palsy. J Neurosurg. 2016;125:264–8.
Guresir E, Schuss P, Seifert V, Vatter H. Oculomotor nerve palsy by posterior communicating artery aneurysms: influence of surgical strategy on recovery. J Neurosurg. 2012;117:904–10.
Stiebel-Kalish H, Kalish Y, Bar-On RH, et al. Presentation, natural history, and management of carotid cavernous aneurysms. Neurosurgery. 2005;57:850–7; discussion -7.
Field M, Jungreis CA, Chengelis N, Kromer H, Kirby L, Yonas H. Symptomatic cavernous sinus aneurysms: management and outcome after carotid occlusion and selective cerebral revascularization. AJNR Am J Neuroradiol. 2003;24:1200–7.
Gonzalez LF, Walker MT, Zabramski JM, Partovi S, Wallace RC, Spetzler RF. Distinction between paraclinoid and cavernous sinus aneurysms with computed tomographic angiography. Neurosurgery. 2003;52:1131–7; discussion 8–9.
van Rooij WJ, Sluzewski M, Beute GN. Ruptured cavernous sinus aneurysms causing carotid cavernous fistula: incidence, clinical presentation, treatment, and outcome. AJNR Am J Neuroradiol. 2006;27:185–9.
Hamada H, Endo S, Fukuda O, Ohi M, Takaku A. Giant aneurysm in the cavernous sinus causing subarachnoid hemorrhage 13 years after detection: a case report. Surg Neurol. 1996;45:143–6.
Kupersmith MJ, Hurst R, Berenstein A, Choi IS, Jafar J, Ransohoff J. The benign course of cavernous carotid artery aneurysms. J Neurosurg. 1992;77:690–3.
Linskey ME, Sekhar LN, Hirsch WL Jr, Yonas H, Horton JA. Aneurysms of the intracavernous carotid artery: natural history and indications for treatment. Neurosurgery. 1990;26:933–7; discussion 7–8.
van der Schaaf I, Algra A, Wermer M, et al. Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2005;4:CD003085.
De Jesus O, Sekhar LN, Riedel CJ. Clinoid and paraclinoid aneurysms: surgical anatomy, operative techniques, and outcome. Surg Neurol. 1999;51:477–88.
Tanaka Y, Hongo K, Tada T, et al. Radiometric analysis of paraclinoid carotid artery aneurysms. J Neurosurg. 2002;96:649–53.
Day AL. Aneurysms of the ophthalmic segment. A clinical and anatomical analysis. J Neurosurg. 1990;72:677–91.
Lee JH, Tobias S, Kwon J-T, Sade B, Kosmorsky G. Wilbrand’s knee: does it exist? Surg Neurol. 2006;66:11–7.
Yadla SMD, Campbell PGMD, Grobelny BBA, et al. Open and endovascular treatment of unruptured carotid-ophthalmic aneurysms: clinical and radiographic outcomes. Neurosurgery. 2011;68:1434–43.
Iihara K, Murao K, Sakai N, et al. Unruptured paraclinoid aneurysms: a management strategy. J Neurosurg. 2003;99:241–7.
Hoh BL, Carter BS, Budzik RF, Putman CM, Ogilvy CS. Results after surgical and endovascular treatment of paraclinoid aneurysms by a combined neurovascular team. Neurosurgery. 2001;48:78–89; discussion -90.
Boet R, Wong GK, Poon WS, Lam JM, Yu SC. Aneurysm recurrence after treatment of paraclinoid/ophthalmic segment aneurysms—a treatment-modality assessment. Acta Neurochir. 2005;147:611–6; discussion 6.
Kim JM, Romano A, Sanan A, van Loveren HR, Keller JT. Microsurgical anatomic features and nomenclature of the paraclinoid region. Neurosurgery. 2000;46:670–80; discussion 80–2.
Matsukawa H, Fujii M, Akaike G, et al. Morphological and clinical risk factors for posterior communicating artery aneurysm rupture. J Neurosurg. 2014;120:104–10.
Leipzig TJ, Morgan J, Horner TG, Payner T, Redelman K, Johnson CS. Analysis of intraoperative rupture in the surgical treatment of 1694 saccular aneurysms. Neurosurgery. 2005;56:455–68; discussion -68.
Lawton MT, Du R. Effect of the neurosurgeon's surgical experience on outcomes from intraoperative aneurysmal rupture. Neurosurgery. 2005;57:9–15; discussion -9.
Piotin M, Mounayer C, Spelle L, Williams MT, Moret J. Endovascular treatment of anterior choroidal artery aneurysms. AJNR Am J Neuroradiol. 2004;25:314–8.
Friedman JA, Pichelmann MA, Piepgras DG, et al. Ischemic complications of surgery for anterior choroidal artery aneurysms. J Neurosurg. 2001;94:565–72.
Miyazawa N, Nukui H, Horikoshi T, Yagishita T, Sugita M, Kanemaru K. Surgical management of aneurysms of the bifurcation of the internal carotid artery. Clin Neurol Neurosurg. 2002;104:103–14.
Sakamoto S, Ohba S, Shibukawa M, et al. Characteristics of aneurysms of the internal carotid artery bifurcation. Acta Neurochir. 2006;148:139–43; discussion 43.
Vargas J, Walsh K, Turner R, Chaudry I, Turk A, Spiotta A. Lenticulostriate aneurysms: a case series and review of the literature. J Neurointerv Surg. 2015;7:194–201.
Heck O, Anxionnat R, Lacour JC, et al. Rupture of lenticulostriate artery aneurysms. J Neurosurg. 2014;120:426–33.
Bijlenga P, Ebeling C, Jaegersberg M, et al. Risk of rupture of small anterior communicating artery aneurysms is similar to posterior circulation aneurysms. Stroke. 2013;44:3018–26.
Yock DH Jr, Larson DA. Computed tomography of hemorrhage from anterior communicating artery aneurysms, with angiographic correlation. Radiology. 1980;134:399–407.
Sayama T, Inamura T, Matsushima T, Inoha S, Inoue T, Fukui M. High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms. Neurol Res. 2000;22:151–5.
Hong JH, Choi BY, Chang CH, et al. Injuries of the cingulum and fornix after rupture of an anterior communicating artery aneurysm: a diffusion tensor tractography study. Neurosurgery. 2012;70:819–23.
Fontanella M, Perozzo P, Ursone R, Garbossa D, Bergui M. Neuropsychological assessment after microsurgical clipping or endovascular treatment for anterior communicating artery aneurysm. Acta Neurochir. 2003;145:867–72; discussion 72.
Elias T, Ogungbo B, Connolly D, Gregson B, Mendelow AD, Gholkar A. Endovascular treatment of anterior communicating artery aneurysms: results of clinical and radiological outcome in Newcastle. Br J Neurosurg. 2003;17:278–86.
Birknes JK, Hwang SK, Pandey AS, et al. Feasibility and limitations of endovascular coil embolization of anterior communicating artery aneurysms: morphological considerations. Neurosurgery. 2006;59:43–52; discussion 43–52.
Steven DA, Ferguson GG. Distal anterior cerebral artery aneurysms. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 1945–57.
Huber P, Braun J, Hirschmann D, Agyeman JF. Incidence of berry aneurysms of the unpaired pericallosal artery: angiographic study. Neuroradiology. 1980;19:143–7.
Inci S, Erbengi A, Ozgen T. Aneurysms of the distal anterior cerebral artery: report of 14 cases and a review of the literature. Surg Neurol. 1998;50:130–9; discussion 9–40.
Hernesniemi J, Tapaninaho A, Vapalahti M, Niskanen M, Kari A, Luukkonen M. Saccular aneurysms of the distal anterior cerebral artery and its branches. Neurosurgery. 1992;31:994–8; discussion 8–9.
Pierot L, Boulin A, Castaings L, Rey A, Moret J. Endovascular treatment of pericallosal artery aneurysms. Neurol Res. 1996;18:49–53.
Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg. 1990;73:18–36.
Rinne J, Hernesniemi J, Niskanen M, Vapalahti M. Analysis of 561 patients with 690 middle cerebral artery aneurysms: anatomic and clinical features as correlated to management outcome. Neurosurgery. 1996;38:2–11.
Stoodley MA, Macdonald RL, Weir BK. Surgical treatment of middle cerebral artery aneurysms. Neurosurg Clin N Am. 1998;9:823–34.
Friedman J, Piepgras D. Middle cerebral artery aneurysms. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 1959–70.
Tokuda Y, Inagawa T, Katoh Y, Kumano K, Ohbayashi N, Yoshioka H. Intracerebral hematoma in patients with ruptured cerebral aneurysms. Surg Neurol. 1995;43:272–7.
Raghavan ML, Ma B, Harbaugh RE. Quantified aneurysm shape and rupture risk. J Neurosurg. 2005;102:355–62.
Regli L, Uske A, de Tribolet N. Endovascular coil placement compared with surgical clipping for the treatment of unruptured middle cerebral artery aneurysms: a consecutive series. J Neurosurg. 1999;90:1025–30.
Doerfler A, Wanke I, Goericke SL, et al. Endovascular treatment of middle cerebral artery aneurysms with electrolytically detachable coils. AJNR Am J Neuroradiol. 2006;27:513–20.
Brinjikji WBS, Lanzino GMD, Cloft HJMDP, Rabinstein AMD, Kallmes DFMD. Endovascular treatment of middle cerebral artery aneurysms: a systematic review and single-center series. Neurosurgery. 2011;68:397–402.
Hänggi DMD, Winkler PAMD, Steiger H-JMD. Primary epileptogenic unruptured intracranial aneurysms: incidence and effect of treatment on epilepsy. Neurosurgery. 2010;66:1161–5.
Patankar T, Hughes D. Resolution of temporal lobe epilepsy and MRI abnormalities after coiling of a cerebral aneurysm. AJR Am J Roentgenol. 2005;185:1664–5.
Kuba R, Krupa P, Okacova L, Rektor I. Unruptured intracranial aneurysm as a cause of focal epilepsy: an excellent postoperative outcome after intra-arterial treatment. Epileptic Disord. 2004;6:41–4.
Lozier AP, Connolly ES Jr, Lavine SD, Solomon RA. Guglielmi detachable coil embolization of posterior circulation aneurysms: a systematic review of the literature. Stroke. 2002;33:2509–18.
Saliou G, Sacho RH, Power S, et al. Natural history and management of basilar trunk artery aneurysms. Stroke. 2015;46:948–53.
Drake CG. The treatment of aneurysms of the posterior circulation. Clin Neurosurg. 1979;26:96–144.
Al-Khayat H, Al-Khayat H, White J, Manner D, Samson D. Upper basilar artery aneurysms: oculomotor outcomes in 163 cases. J Neurosurg. 2005;102:482–8.
Henkes H, Fischer S, Mariushi W, et al. Angiographic and clinical results in 316 coil-treated basilar artery bifurcation aneurysms. J Neurosurg. 2005;103:990–9.
Nehls DG, Flom RA, Carter LP, Spetzler RF. Multiple intracranial aneurysms: determining the site of rupture. J Neurosurg. 1985;63:342–8.
Kwon OK, Kim SH, Kwon BJ, et al. Endovascular treatment of wide-necked aneurysms by using two microcatheters: techniques and outcomes in 25 patients. AJNR Am J Neuroradiol. 2005;26:894–900.
Benndorf G, Claus B, Strother CM, Chang L, Klucznik RP. Increased cell opening and prolapse of struts of a neuroform stent in curved vasculature: value of angiographic computed tomography: technical case report. Neurosurgery. 2006;58:ONS-E380; discussion ONS-E.
Josephson SA, Dillon WP, Dowd CF, Malek R, Lawton MT, Smith WS. Continuous bleeding from a basilar terminus aneurysm imaged with CT angiography and conventional angiography. Neurocrit Care. 2004;1:103–6.
Goehre F, Jahromi BR, Hernesniemi J, et al. Characteristics of posterior cerebral artery aneurysms: an angiographic analysis of 93 aneurysms in 81 patients. Neurosurgery. 2014;75:134–44; discussion 43–4; quiz 44.
Hamada J, Morioka M, Yano S, Todaka T, Kai Y, Kuratsu J. Clinical features of aneurysms of the posterior cerebral artery: a 15-year experience with 21 cases. Neurosurgery. 2005;56:662–70; discussion -70.
Ciceri EF, Klucznik RP, Grossman RG, Rose JE, Mawad ME. Aneurysms of the posterior cerebral artery: classification and endovascular treatment. AJNR Am J Neuroradiol. 2001;22:27–34.
Honda M, Tsutsumi K, Yokoyama H, Yonekura M, Nagata I. Aneurysms of the posterior cerebral artery: retrospective review of surgical treatment. Neurol Med Chir (Tokyo). 2004;44:164–8; discussion 9.
Chang SWMD, Abla AAMD, Kakarla UKMD, et al. Treatment of distal posterior cerebral artery aneurysms: a critical appraisal of the occipital artery-to-posterior cerebral artery bypass. Neurosurgery. 2010;67:16–26.
Hallacq P, Piotin M, Moret J. Endovascular occlusion of the posterior cerebral artery for the treatment of P2 segment aneurysms: retrospective review of a 10-year series. AJNR Am J Neuroradiol. 2002;23:1128–36.
Haw C, Willinsky R, Agid R, TerBrugge K. The endovascular management of superior cerebellar artery aneurysms. Can J Neurol Sci. 2004;31:53–7.
Danet M, Raymond J, Roy D. Distal superior cerebellar artery aneurysm presenting with cerebellar infarction: report of two cases. AJNR Am J Neuroradiol. 2001;22:717–20.
Eckard DA, O’Boynick PL, McPherson CM, et al. Coil occlusion of the parent artery for treatment of symptomatic peripheral intracranial aneurysms. AJNR Am J Neuroradiol. 2000;21:137–42.
Drake CG, Peerless SJ, Hernesniemi JA. Surgery of vertebrobasilar aneurysms: London, Ontario, experience on 1767 patients. Vienna: Springer; 1996.
Peerless SJ, Drake CG. Posterior circulation aneurysms. In: Wilkins RH, Rengachary SS, editors. Neurosurgery. New York: McGraw-Hill; 1996. p. 2341–56.
Seifert V. Direct surgery of basilar trunk and vertebrobasilar junction aneurysms via the combined transpetrosal approach. Neurol Med Chir (Tokyo). 1998;38(Suppl):86–92.
Van Rooij WJ, Sluzewski M, Menovsky T, Wijnalda D. Coiling of saccular basilar trunk aneurysms. Neuroradiology. 2003;45:19–21.
Uda K, Murayama Y, Gobin YP, Duckwiler GR, Vinuela F. Endovascular treatment of basilar artery trunk aneurysms with Guglielmi detachable coils: clinical experience with 41 aneurysms in 39 patients. J Neurosurg. 2001;95:624–32.
Wenderoth JD, Khangure MS, Phatouros CC, ApSimon HT. Basilar trunk occlusion during endovascular treatment of giant and fusiform aneurysms of the basilar artery. AJNR Am J Neuroradiol. 2003;24:1226–9.
Gonzalez LF, Alexander MJ, McDougall CG, Spetzler RF. Anteroinferior cerebellar artery aneurysms: surgical approaches and outcomes—a review of 34 cases. Neurosurgery. 2004;55:1025–35.
Akyuz M, Tuncer R. Multiple anterior inferior cerebellar artery aneurysms associated with an arteriovenous malformation: case report. Surg Neurol. 2005;64(Suppl 2):S106–8.
Suzuki K, Meguro K, Wada M, Fujita K, Nose T. Embolization of a ruptured aneurysm of the distal anterior inferior cerebellar artery: case report and review of the literature. Surg Neurol. 1999;51:509–12.
Yoon SM, Chun YI, Kwon Y, Kwun BD. Vertebrobasilar junction aneurysms associated with fenestration: experience of five cases treated with Guglielmi detachable coils. Surg Neurol. 2004;61:248–54.
Rabinov JD, Hellinger FR, Morris PP, Ogilvy CS, Putman CM. Endovascular management of vertebrobasilar dissecting aneurysms. AJNR Am J Neuroradiol. 2003;24:1421–8.
Hudgins RJ, Day AL, Quisling RG, Rhoton AL Jr, Sypert GW, Garcia-Bengochea F. Aneurysms of the posterior inferior cerebellar artery. A clinical and anatomical analysis. J Neurosurg. 1983;58:381–7.
Yamaura A, Watanabe Y, Saeki N. Dissecting aneurysms of the intracranial vertebral artery. J Neurosurg. 1990;72:183–8.
Kallmes DF, Lanzino G, Dix JE, et al. Patterns of hemorrhage with ruptured posterior inferior cerebellar artery aneurysms: CT findings in 44 cases. AJR Am J Roentgenol. 1997;169:1169–71.
Yamaura A. Diagnosis and treatment of vertebral aneurysms. J Neurosurg. 1988;69:345–9.
Lemole GM Jr, Henn J, Javedan S, Deshmukh V, Spetzler RF. Cerebral revascularization performed using posterior inferior cerebellar artery-posterior inferior cerebellar artery bypass. Report of four cases and literature review. J Neurosurg. 2002;97:219–23.
Mericle RA, Reig AS, Burry MV, Eskioglu E, Firment CS, Santra S. Endovascular surgery for proximal posterior inferior cerebellar artery aneurysms: an analysis of Glasgow outcome score by hunt-Hess grades. Neurosurgery. 2006;58:619–25; discussion -25.
Lewis SB, Chang DJ, Peace DA, Lafrentz PJ, Day AL. Distal posterior inferior cerebellar artery aneurysms: clinical features and management. J Neurosurg. 2002;97:756–66.
Horiuchi T, Tanaka Y, Hongo K, Nitta J, Kusano Y, Kobayashi S. Characteristics of distal posteroinferior cerebellar artery aneurysms. Neurosurgery. 2003;53:589–95; discussion 95–6.
Orakcioglu B, Schuknecht B, Otani N, Khan N, Imhof HG, Yonekawa Y. Distal posterior inferior cerebellar artery aneurysms: clinical characteristics and surgical management. Acta Neurochir. 2005;147:1131–9.
Heros RC. Posterior inferior cerebellar artery. J Neurosurg. 2002;97:747–8; discussion 8.
Werner S, Blakemore A, King B. Aneurysm of the internal carotid artery within the skull: wiring and electrothermic coagulation. JAMA. 1941;116:578–82.
Mullan S, Raimondi AJ, Dobben G, Vailati G, Hekmatpanah J. Electrically induced thrombosis in intracranial aneurysms. J Neurosurg. 1965;22:539–47.
Gallagher JP. Obliteration of intracranial aneurysms by pilojection. JAMA. 1963;183:231–6.
Alksne JF, Fingerhut AG. Magnetically controlled metallic thrombosis of intracranial aneurysms. A preliminary report. Bull Los Angel Neurol Soc. 1965;30:153–5.
Luessenhop AJ, Velasquez AC. Observations on the tolerance of the intracranial arteries to catheterization. J Neurosurg. 1964;21:85–91.
Teitelbaum GP, Larsen DW, Zelman V, Lysachev AG, Likhterman LB. A tribute to Dr. Fedor a. Serbinenko, founder of endovascular neurosurgery. Neurosurgery. 2000;46:462–9; discussion 9–70.
Serbinenko FA. Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg. 1974;41:125–45.
Debrun G, Lacour P, Caron JP, Hurth M, Comoy J, Keravel Y. Detachable balloon and calibrated-leak balloon techniques in the treatment of cerebral vascular lesions. J Neurosurg. 1978;49:635–49.
Hieshima GB, Grinnell VS, Mehringer CM. A detachable balloon for therapeutic transcatheter occlusions. Radiology. 1981;138:227–8.
Kwan ES, Heilman CB, Shucart WA, Klucznik RP. Enlargement of basilar artery aneurysms following balloon occlusion—“water-hammer effect”. Report of two cases. J Neurosurg. 1991;75:963–8.
Gianturco C, Anderson JH, Wallace S. Mechanical devices for arterial occlusion. Am J Roentgenol Radium Therapy, Nucl Med. 1975;124:428–35.
Higashida RT, Halbach VV, Dowd CF, Barnwell SL, Hieshima GB. Interventional neurovascular treatment of a giant intracranial aneurysm using platinum microcoils. Surg Neurol. 1991;35:64–8.
Hilal SK, Solomon RA. Endovascular treatment of aneurysms with coils. J Neurosurg. 1992;76:337–9.
Molyneux AJ, Clarke A, Sneade M, et al. Cerecyte coil trial: angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils. Stroke. 2012;43:2544–50.
McDougall CG, Johnston SC, Gholkar A, et al. Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (matrix and platinum science) trial. AJNR Am J Neuroradiol. 2014;35:935–42.
Moret J, Cognard C, Weill A, Castaings L, Rey A. Reconstruction technic in the treatment of wide-neck intracranial aneurysms. Long-term angiographic and clinical results. Apropos of 56 cases. J Neuroradiol. 1997;24:30–44.
Qureshi AI, Vazquez G, Tariq N, Suri MFK, Lakshminarayan K, Lanzino G. Impact of international subarachnoid aneurysm trial results on treatment of ruptured intracranial aneurysms in the United States. J Neurosurg. 2011;114:834–41.
Ellis JA, McDowell MM, Mayer SA, Lavine SD, Meyers PM, Connolly ES Jr. The role of antiplatelet medications in angiogram-negative subarachnoid hemorrhage. Neurosurgery. 2014;75:530–5; discussion 4–5.
Elhadi AM, Zabramski JM, Almefty KK, et al. Spontaneous subarachnoid hemorrhage of unknown origin: hospital course and long-term clinical and angiographic follow-up. J Neurosurg. 2015;122:663–70.
Flaherty ML, Haverbusch M, Kissela B, et al. Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis. 2005;14:267–71.
Konczalla J, Kashefiolasl S, Brawanski N, Senft C, Seifert V, Platz J. Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor? J Neurosurg. 2016;124:1731–7.
Kalra VB, Wu X, Forman HP, Malhotra A. Cost-effectiveness of angiographic imaging in isolated perimesencephalic subarachnoid hemorrhage. Stroke. 2014;45:3576–82.
Brinjikji W, Kallmes DF, White JB, Lanzino G, Morris JM, Cloft HJ. Inter- and intraobserver agreement in CT characterization of nonaneurysmal perimesencephalic subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2010;31:1103–5.
van der Schaaf IC, Velthuis BK, Gouw A, Rinkel GJ. Venous drainage in perimesencephalic hemorrhage. Stroke. 2004;35:1614–8.
Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke. 1988;19:1159–70.
Edlow BL, Kasner SE, Hurst RW, Weigele JB, Levine JM. Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage. Neurocrit Care. 2007;7:203–10.
Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke. 2010;41:2505–11.
Ducros A. Reversible cerebral vasoconstriction syndrome. Presse Med. 2010;39:312–22.
Chen SP, Fuh JL, Lirng JF, Chang FC, Wang SJ. Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? Neurology. 2006;67:2164–9.
Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum. 2002;47:662–9.
Labovitz DL, Halim AX, Brent B, Boden-Albala B, Hauser WA, Sacco RL. Subarachnoid hemorrhage incidence among whites, blacks and Caribbean Hispanics: the northern Manhattan study. Neuroepidemiology. 2006;26:147–50.
Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke. 1994;25:2315–28.
Dupont SA, Lanzino G, Wijdicks EFM, Rabinstein AA. The use of clinical and routine imaging data to differentiate between aneurysmal and nonaneurysmal subarachnoid hemorrhage prior to angiography. J Neurosurg. 2010;113(4):790.
van Gijn J, Rinkel GJE. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249–78.
Polmear A. Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review. Cephalalgia. 2003;23:935–41.
Frizzell RT, Kuhn F, Morris R, Quinn C, Fisher WS 3rd. Screening for ocular hemorrhages in patients with ruptured cerebral aneurysms: a prospective study of 99 patients. Neurosurgery. 1997;41:529–33; discussion 33–4.
Pfausler B, Belcl R, Metzler R, Mohsenipour I, Schmutzhard E. Terson's syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients. J Neurosurg. 1996;85:392–4.
McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson’s syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004;75:491–3.
Koskela E, Pekkola J, Kivisaari R, et al. Comparison of CT and clinical findings of Terson's syndrome in 121 patients: a 1-year prospective study. J Neurosurg. 2014;120:1172–8.
Tsementzis SA, Williams A. Ophthalmological signs and prognosis in patients with a subarachnoid haemorrhage. Neurochirurgia (Stuttg). 1984;27:133–5.
Pinto AN, Canhao P, Ferro JM. Seizures at the onset of subarachnoid haemorrhage. J Neurol. 1996;243:161–4.
Dubosh NM, Bellolio MF, Rabinstein AA, Edlow JA. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Stroke. 2016;47:750–5.
Bambakidis N, Selman W. Subarachnoid hemorrhage. In: Suarez JI, editor. Critical care neurology and neurosurgery. Totowa, NJ: Humana Press; 2004. p. 365–77.
Backes D, Rinkel GJ, Kemperman H, Linn FH, Vergouwen MD. Time-dependent test characteristics of head computed tomography in patients suspected of nontraumatic subarachnoid hemorrhage. Stroke. 2012;43:2115–9.
Walton JN. Subarachnoid Haemorrhage. Edinburgh: E&S Livingtone; 1956.
Marshman LA, Duell R, Rudd D, Johnston R, Faris C. Intraobserver and interobserver agreement in visual inspection for xanthochromia: implications for subarachnoid hemorrhage diagnosis, computed tomography validation studies, and the Walton rule. Neurosurgery. 2014;74:395–9; discussion 9–400.
Ungerer JP, Southby SJ, Florkowski CM, George PM. Automated measurement of cerebrospinal fluid bilirubin in suspected subarachnoid hemorrhage. Clin Chem. 2004;50:1854–6.
Heasley DC, Mohamed MA, Yousem DM. Clearing of red blood cells in lumbar puncture does not rule out ruptured aneurysm in patients with suspected subarachnoid hemorrhage but negative head CT findings. AJNR Am J Neuroradiol. 2005;26:820–4.
Wallace AN, Dines JN, Zipfel GJ, Derdeyn CP. Yield of catheter angiography after computed tomography negative, lumbar puncture positive subarachnoid hemorrhage [corrected]. Stroke. 2013;44:1729–31.
Villablanca JP, Jahan R, Hooshi P, et al. Detection and characterization of very small cerebral aneurysms by using 2D and 3D helical CT angiography. AJNR Am J Neuroradiol. 2002;23:1187–98.
Jayaraman MV, Mayo-Smith WW, Tung GA, et al. Detection of intracranial aneurysms: multi-detector row CT angiography compared with DSA. Radiology. 2004;230:510–8.
Rogg JM, Smeaton S, Doberstein C, Goldstein JH, Tung GA, Haas RA. Assessment of the value of MR imaging for examining patients with angiographically negative subarachnoid hemorrhage. AJR Am J Roentgenol. 1999;172:201–6.
Maslehaty H, Petridis AK, Barth H, Mehdorn HM. Diagnostic value of magnetic resonance imaging in perimesencephalic and nonperimesencephalic subarachnoid hemorrhage of unknown origin. J Neurosurg. 2011;114:1003–7.
Bakker NA, Groen RJ, Foumani M, et al. Repeat digital subtraction angiography after a negative baseline assessment in nonperimesencephalic subarachnoid hemorrhage: a pooled data meta-analysis. J Neurosurg. 2014;120:99–103.
Delgado Almandoz JE, Jagadeesan BD, Refai D, et al. Diagnostic yield of repeat catheter angiography in patients with catheter and computed tomography angiography negative subarachnoid hemorrhage. Neurosurgery. 2012;70:1135–42.
Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50:1413–8.
Qureshi AI, Suri MF, Nasar A, et al. Trends in hospitalization and mortality for subarachnoid hemorrhage and unruptured aneurysms in the United States. Neurosurgery. 2005;57:1–8; discussion 1–8.
Fischer T, Johnsen SP, Pedersen L, Gaist D, Sorensen HT, Rothman KJ. Seasonal variation in hospitalization and case fatality of subarachnoid hemorrhage—a nationwide danish study on 9,367 patients. Neuroepidemiology. 2005;24:32–7.
Biotti DMD, Jacquin AMD, Boutarbouch MMD, et al. Trends in case-fatality rates in hospitalized nontraumatic subarachnoid hemorrhage: results of a population-based study in Dijon, France, From 1985 to 2006. Neurosurgery. 2010;66:1039–43.
Tsutsumi K, Ueki K, Morita A, Kirino T. Risk of rupture from incidental cerebral aneurysms. J Neurosurg. 2000;93:550–3.
Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994;25(7):1342.
Schievink WI, Wijdicks EF, Piepgras DG, Chu CP, O'Fallon WM, Whisnant JP. The poor prognosis of ruptured intracranial aneurysms of the posterior circulation. J Neurosurg. 1995;82(5):791.
van Donkelaar CE, Bakker NA, Veeger NJ, et al. Predictive factors for rebleeding after aneurysmal subarachnoid hemorrhage: rebleeding aneurysmal subarachnoid hemorrhage study. Stroke. 2015;46:2100–6.
Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg. 1996;84:35–42.
Brilstra EH, Rinkel GJ, Algra A, van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology. 2000;55:1656–60.
Steiger HJ, Fritschi J, Seiler RW. Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir. 1994;127:21–6.
Khurana VG, Piepgras DG, Whisnant JP. Ruptured giant intracranial aneurysms. Part I. A study of rebleeding. J Neurosurg. 1998;88:425–9.
Jane JA, Kassell NF, Torner JC, Winn HR. The natural history of aneurysms and arteriovenous malformations. J Neurosurg. 1985;62(3):321.
Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62:410–6.
Juvela S. Rebleeding from ruptured intracranial aneurysms. Surg Neurol. 1989;32:323–6.
Fodstad H, Liliequist B, Schannong M, Thulin CA. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Surg Neurol. 1978;10:9–15.
Kassell NF, Torner JC, Adams HP Jr. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the cooperative aneurysm study. J Neurosurg. 1984;61:225–30.
Vermeulen M, van Gijn J, Hijdra A, van Crevel H. Causes of acute deterioration in patients with a ruptured intracranial aneurysm. A prospective study with serial CT scanning. J Neurosurg. 1984;60:935–9.
Burchiel KJ, Hoffman JM, Bakay RA. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition. Neurosurgery. 1984;14:57–63.
Starke RM, Kim GH, Fernandez A, et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke. 2008;39:2617–21.
Harrigan MR, Rajneesh KF, Ardelt AA, Fisher WS 3rd. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery. 2010;67:935–9; discussion 9–40.
Hui FK, Schuette AJ, Lieber M, et al. Epsilon aminocaproic acid in angiographically negative subarachnoid hemorrhage patients is safe: a retrospective review of 83 consecutive patients. Neurosurgery. 2012;70(3):702–5; discussion 705–6.
Germans MR, Post R, Coert BA, Rinkel GJ, Vandertop WP, Verbaan D. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial. Trials. 2013;14:143.
Leipzig TJ, Redelman K, Horner TG. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. J Neurosurg. 1997;86:220–5.
Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97:771–8.
Vale FL, Bradley EL, Fisher WS 3rd. The relationship of subarachnoid hemorrhage and the need for postoperative shunting. J Neurosurg. 1997;86:462–6.
Malekpour M, Kulwin C, Bohnstedt BN, et al. Effect of short-term epsilon-aminocaproic acid treatment on patients undergoing endovascular coil embolization following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2017;126:1606–13.
Foreman PM, Chua M, Harrigan MR, et al. Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: a case-control study. Clin Neurol Neurosurg. 2015;139:66–9.
Haley EC Jr, Kassell NF, Torner JC. The international cooperative study on the timing of aneurysm surgery. The north American experience. Stroke. 1992;23:205–14.
Ohman J, Heiskanen O. Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J Neurosurg. 1989;70:55–60.
Phillips TJ, Dowling RJ, Yan B, Laidlaw JD, Mitchell PJ. Does treatment of ruptured intracranial aneurysms within 24 hours improve clinical outcome? Stroke. 2011;42:1936–45.
Suarez-Rivera O. Acute hydrocephalus after subarachnoid hemorrhage. Surg Neurol. 1998;49(5):563.
Dehdashti AR, Rilliet B, Rufenacht DA, de Tribolet N. Shunt-dependent hydrocephalus after rupture of intracranial aneurysms: a prospective study of the influence of treatment modality. J Neurosurg. 2004;101:402–7.
Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke. 1989;20:747–53.
Pare L, Delfino R, Leblanc R. The relationship of ventricular drainage to aneurysmal rebleeding. J Neurosurg. 1992;76:422–7.
Voldby B, Enevoldsen EM. Intracranial pressure changes following aneurysm rupture. Part 3: recurrent hemorrhage. J Neurosurg. 1982;56:784–9.
O'Kelly CJ, Kulkarni AV, Austin PC, Urbach D, Wallace MC. Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: incidence, predictors, and revision rates. Clinical article. J Neurosurg. 2009;111:1029–35.
Komotar RJ, Hahn DK, Kim GH, et al. Efficacy of lamina terminalis fenestration in reducing shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage: a systematic review. Clinical article. J Neurosurg. 2009;111:147–54.
Adams H, Ban VS, Leinonen V, et al. Risk of shunting after aneurysmal subarachnoid hemorrhage: a collaborative study and initiation of a consortium. Stroke. 2016;47:2488–96.
Zaidi HA, Montoure A, Elhadi A, et al. Long-term functional outcomes and predictors of shunt-dependent hydrocephalus after treatment of ruptured intracranial aneurysms in the BRAT trial: revisiting the clip vs coil debate. Neurosurgery. 2015;76:608–13; discussion 13–4; quiz 14.
Klopfenstein JD, Kim LJ, Feiz-Erfan I, et al. Comparison of rapid and gradual weaning from external ventricular drainage in patients with aneurysmal subarachnoid hemorrhage: a prospective randomized trial. J Neurosurg. 2004;100:225–9.
Rhoney DH, Tipps LB, Murry KR, Basham MC, Michael DB, Coplin WM. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology. 2000;55:258–65.
Ibrahim GM, Fallah A, Macdonald RL. Clinical, laboratory, and radiographic predictors of the occurrence of seizures following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2013;119:347–52.
Panczykowski D, Pease M, Zhao Y, et al. Prophylactic antiepileptics and seizure incidence following subarachnoid hemorrhage: a propensity score-matched analysis. Stroke. 2016;47:1754–60.
Rosengart AJ, Huo JD, Tolentino J, et al. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg. 2007;107:253–60.
Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36:583–7.
Baker CJ, Prestigiacomo CJ, Solomon RA. Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery. 1995;37:863–70; discussion 70–1.
Claassen J, Peery S, Kreiter KT, et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology. 2003;60:208–14.
Lin CL, Dumont AS, Lieu AS, et al. Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;99:978–85.
Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the multicenter cooperative aneurysm study. Crit Care Med. 1995;23:1007–17.
Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage: new strategies for prevention and management. Curr Opin Crit Care. 2006;12:78–84.
Sarrafzadeh AMD, Schlenk FMD, Meisel AMD, Dreier JMD, Vajkoczy PMD, Meisel CMD. Immunodepression after aneurysmal subarachnoid hemorrhage. Stroke. 2011;42:53–8.
Dorhout Mees SM, van Dijk GW, Algra A, Kempink DRJ, Rinkel GJE. Glucose levels and outcome after subarachnoid hemorrhage. Neurology. 2003;61:1132–3.
Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617–23; quiz 24.
Frontera JA, Fernandez A, Claassen J, et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke. 2006;37:199–203.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–32.
Allport LE, Butcher KS, Baird TA, et al. Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke. 2004;35:1886–91.
Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.
Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol. 1990;27:106–8.
Kurokawa Y, Uede T, Ishiguro M, et al. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol. 1996;46:500–7; discussion 7–8.
Qureshi AI, Suri MF, Sung GY, et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;50:749–55; discussion 55–6.
Sherlock M, O'Sullivan E, Agha A, et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol. 2006;64:250–4.
Morinaga K, Hayashi S, Matsumoto Y, et al. Hyponatremia and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. No To Shinkei. 1992;44:629–32.
Moro N, Katayama Y, Kojima J, Mori T, Kawamata T. Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke. 2003;34:2807–11.
Wijdicks EF, Vandongen KJ, Vangijn J, Hijdra A, Vermeulen M. Enlargement of the third ventricle and hyponatraemia in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1988;51:516–20.
Harrigan MR. Cerebral salt wasting syndrome. Crit Care Clin. 2001;17:125–38.
Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol. 1985;18:211–6.
MJ MG, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery. 2004;54:1369–73; discussion 73–4.
Tomida M, Muraki M, Uemura K, Yamasaki K. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke. 1998;29:1584–7.
Tung PP, Olmsted E, Kopelnik A, et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke. 2005;36:1567–9.
Sviri GE, Feinsod M, Soustiel JF. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage: clinical and TCD correlations. Stroke. 2000;31:118–22.
Takahashi K, Totsune K, Sone M, et al. Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides. 1992;13:121–3.
Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 1997;349:245–9.
Takaku A, Shindo K, Tanaka S, Mori T, Suzuki J. Fluid and electrolyte disturbances in patients with intracranial aneurysms. Surg Neurol. 1979;11:349–56.
van den Bergh WM, Algra A, Rinkel GJE. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke. 2004;35:644–8.
Fukui S, Otani N, Katoh H, et al. Female gender as a risk factor for hypokalemia and QT prolongation after subarachnoid hemorrhage. Neurology. 2002;59:134–6.
Fukui S, Katoh H, Tsuzuki N, et al. Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage. Crit Care. 2003;7:R7–R12.
Machado C, Baga JJ, Kawasaki R, Reinoehl J, Steinman RT, Lehmann MH. Torsade de pointes as a complication of subarachnoid hemorrhage: a critical reappraisal. J Electrocardiol. 1997;30:31–7.
van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52:276–81; discussion 81–2.
Collignon FP, Friedman JA, Piepgras DG, et al. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2004;1:441–8.
Brouwers PJ, Wijdicks EF, Hasan D, et al. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke. 1989;20:1162–7.
Marion DW, Segal R, Thompson ME. Subarachnoid hemorrhage and the heart. Neurosurgery. 1986;18:101–6.
Manninen PH, Ayra B, Gelb AW, Pelz D. Association between electrocardiographic abnormalities and intracranial blood in patients following acute subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1995;7:12–6.
Andreoli A, di Pasquale G, Pinelli G, Grazi P, Tognetti F, Testa C. Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. Stroke. 1987;18:558–64.
Kuroiwa T, Morita H, Tanabe H, Ohta T. Significance of ST segment elevation in electrocardiograms in patients with ruptured cerebral aneurysms. Acta Neurochir. 1995;133:141–6.
Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30:780–6.
Fink JN, Selim MH, Kumar S, Voetsch B, Fong WC, Caplan LR. Insular cortex infarction in acute middle cerebral artery territory stroke: predictor of stroke severity and vascular lesion. Arch Neurol. 2005;62:1081–5.
Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24:636–40.
Tung P, Kopelnik A, Banki N, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35:548–51.
Banki NM, Kopelnik A, Dae MW, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314–9.
Schuiling WJ, Dennesen PJW, Tans JTJ, Kingma LM, Algra A, Rinkel GJE. Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2005;76:1565–9.
Jain R, Deveikis J, Thompson BG. Management of patients with stunned myocardium associated with subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2004;25:126–9.
Naval NS, Stevens RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2006;34:511–24.
Obata Y, Takeda J, Sato Y, Ishikura H, Matsui T, Isotani E. A multicenter prospective cohort study of volume management after subarachnoid hemorrhage: circulatory characteristics of pulmonary edema after subarachnoid hemorrhage. J Neurosurg. 2016;125:254–63.
Kopelnik A, Fisher L, Miss JC, et al. Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care. 2005;3:132–8.
Friedman JA, Pichelmann MA, Piepgras DG, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52:1025–31; discussion 31–2.
Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med. 2006;34:196–202.
Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med. 2002;28:1012–23.
Knudsen F, Jensen HP, Petersen PL. Neurogenic pulmonary edema: treatment with dobutamine. Neurosurgery. 1991;29:269–70.
Can A, Gross BA, Smith TR, et al. Pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurgery. 2016;79:253–64.
Findley JM. Cerebral vasospasm. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 1839–67.
Macdonald RL. Management of cerebral vasospasm. Neurosurg Rev. 2006. https://doi.org/10.1007/s10143-005-0013-5.
Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg. 1997;86:467–74.
Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg. 1996;84:221–8.
Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg. 1978;48:173–8.
Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarchnoid hemorrhage: incidence and effects. J Clin Neurosci. 1994;1:19–26.
Yamaguchi M, Bun T, Kuwahara T, Kitamura S. Very late-onset symptomatic cerebral vasospasm caused by a large residual aneurysmal subarachnoid hematoma—case report. Neurol Med Chir (Tokyo). 1999;39:677–80.
Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the fisher scale revisited. Stroke. 2001;32:2012–20.
Howington JU, Kutz SC, Wilding GE, Awasthi D. Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;99:271–5.
Beadell NC, Thompson EM, Delashaw JB, Cetas JS. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2012;117:781–6.
Behrouz R, Birnbaum L, Grandhi R, et al. Cannabis use and outcomes in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2016;47:1371–3.
Ryttlefors MMDP, Enblad PMDP, Ronne-Engstrom EMDP, Persson LMDP, Ilodigwe DP, Macdonald RLMDP. Patient age and vasospasm after subarachnoid hemorrhage. Neurosurgery. 2010;67:911–7.
Hoh BL, Topcuoglu MA, Singhal AB, et al. Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2004;55:779–86; discussion 86–9.
Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg. 2003;98:319–25.
Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med. 2004;32(6):1272.
Jaeger M, Soehle M, Schuhmann MU, Meixensberger J. Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage. Stroke. 2012;43:2097–101.
Yoon DY, Choi CS, Kim KH, Cho BM, Multidetector-Row CT. Angiography of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: comparison of volume-rendered images and digital subtraction angiography. AJNR Am J Neuroradiol. 2006;27:370–7.
Harrigan MR, Leonardo J, Gibbons KJ, Guterman LR, Hopkins LN. CT perfusion cerebral blood flow imaging in neurological critical care. Neurocrit Care. 2005;2:352–66.
Wintermark M, Ko NU, Smith WS, Liu S, Higashida RT, Dillon WP. Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol. 2006;27:26–34.
Clyde BL, Resnick DK, Yonas H, Smith HA, Kaufmann AM. The relationship of blood velocity as measured by transcranial doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1996;38:896–904; discussion -5.
Lysakowski C, Walder B, Costanza MC, Tramer MR. Transcranial doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke. 2001;32:2292–8.
Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg. 1984;60:37–41.
Burch CM, Wozniak MA, Sloan MA, et al. Detection of intracranial internal carotid artery and middle cerebral artery vasospasm following subarachnoid hemorrhage. J Neuroimaging. 1996;6:8–15.
Wozniak MA, Sloan MA, Rothman MI, et al. Detection of vasospasm by transcranial Doppler sonography. The challenges of the anterior and posterior cerebral arteries. J Neuroimaging. 1996;6:87–93.
Sloan MA, Burch CM, Wozniak MA, et al. Transcranial Doppler detection of vertebrobasilar vasospasm following subarachnoid hemorrhage. Stroke. 1994;25:2187–97.
Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124:1257–64.
Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien). 1988;42:81–4.
Soustiel JF, Shik V, Shreiber R, Tavor Y, Goldsher D, Muizelaar JP. Basilar vasospasm diagnosis: investigation of a modified “Lindegaard index” based on imaging studies and blood velocity measurements of the basilar artery * editorial comment: investigation of a modified “Lindegaard index” based on imaging studies and blood velocity measurements of the basilar artery. Stroke. 2002;33:72–8.
Barker FG 2nd, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg. 1996;84:405–14.
Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir. 1986;82:110–4.
Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.
Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2005;3:CD000277.
Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P, Wolf S. Nimodipine dose reductions in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2016;25:29–39.
Hanggi D, Etminan N, Aldrich F, et al. Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (NEWTON [Nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]). Stroke. 2017;48:145–51.
Wong MC, Haley EC Jr. Calcium antagonists: stroke therapy coming of age. Stroke. 1990;21:494–501.
Toyota BD. The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage. J Neurosurg. 1999;90:203–6.
Endres M. Statins and stroke. J Cereb Blood Flow Metab. 2005;25:1093–110.
Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53:743–51.
MJ MG, Pradilla G, Legnani FG, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery. 2006;58:945–51; discussion -51.
Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36:1627–32.
Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005;36:2024–6.
Chou SH, Smith EE, Badjatia N, et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:2891–3.
Wong GK, Chan DY, Siu DY, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial. Stroke. 2015;46:382–8.
Shen J, Huang KY, Zhu Y, et al. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016:1–11.
Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. J Neurosurg. 2013;119:180–9.
Pfeffer MA, Keech A, Sacks FM, et al. Safety and tolerability of pravastatin in long-term clinical trials: prospective pravastatin pooling (PPP) project. Circulation. 2002;105:2341–6.
UpToDate. Pravastatin: Drug Information. Lexi-Comp, Inc.; 2007.
Tseng MY, Hutchinson PJ, Turner CL, et al. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial. J Neurosurg. 2007;107:1092–100.
Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 2004;100:215–24.
Kwon OY, Kim YJ, Cho CS, Lee SK, Cho MK. The utility and benefits of external lumbar CSF drainage after endovascular coiling on aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc. 2008;43:281–7.
Staykov DMD, Speck VMD, Volbers BMD, et al. Early recognition of lumbar overdrainage by lumboventricular pressure gradient. Neurosurgery. 2011;68:1187–91.
van den Bergh WM, Zuur JK, Kamerling NA, et al. Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg. 2002;97:416–22.
Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth. 1999;83:302–20.
Euser AG, Cipolla MJ. Resistance artery vasodilation to magnesium sulfate during pregnancy and the postpartum state. Am J Physiol Heart Circ Physiol. 2005;288:H1521–5.
van den Bergh WM, On behalf of the MSG. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–5.
Wong GK, Poon WS, Chan MT, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921–6.
Wong GKCF, Poon WSFF, Chan MTVF, et al. Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: post hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial. Stroke. 2010;41:1841–4.
Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2007;78:729–31.
Dorhout Mees SM, Algra A, Wong GK, et al. Early magnesium treatment after aneurysmal subarachnoid hemorrhage: individual patient data meta-analysis. Stroke. 2015;46:3190–3.
Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“triple-H” therapy) after subarachnoid hemorrhage. Neurosurgery. 1990;27:729–39; discussion 39–40.
Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98:978–84.
Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31:383–91.
Feigin VL, Rinkel GJ, Algra A, van Gijn J. Circulatory volume expansion for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev. 2000;2:CD000483.
Rinkel GJ, Feigin VL, Algra A, van Gijn J. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2004;4:CD000483.
Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49:593–605; discussion -6.
Raabe A, Beck J, Berkefeld J, et al. Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage. Zentralbl Neurochir. 2005;66:79–91.
Ramakrishna RMD, Sekhar LNMDF, Ramanathan DMD, et al. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2010;67:110–7.
Muehlschlegel SMDMPH, Rordorf GMD, Sims JMD. Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study. Stroke. 2011;42:1301–6.
Al-Rawi PGB, Tseng M-YP, Richards HKP, et al. Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood flow, brain tissue oxygen, and pH. Stroke. 2010;41:122–8.
Hoh BL, Carter BS, Ogilvy CS. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy. Neurosurgery. 2002;50:1207–11; discussion 11–2.
Shimoda M, Oda S, Tsugane R, Sato O. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg. 1993;78:423–9.
Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2005;103:974–81.
Harrigan MR. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm. Crit Care. 2010;14:151.
Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14:R23.
Gathier CS, Dankbaar JW, van der Jagt M, et al. Effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2015;46:3277–81.
Giannotta SL, McGillicuddy JE, Kindt GW. Diagnosis and treatment of postoperative cerebral vasospasm. Surg Neurol. 1977;8:286–90.
Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987;18:365–72.
Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery. 1983;12:658–61.
Corsten L, Raja A, Guppy K, et al. Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience. Surg Neurol. 2001;56:140–8; discussion 8–50.
Joseph M, Ziadi S, Nates J, Dannenbaum M, Malkoff M. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery. 2003;53:1044–51; discussion 51–2.
Mayer SA, Solomon RA, Fink ME, et al. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery. 1998;42:759–67; discussion 67–8.
Ekelund A, Reinstrup P, Ryding E, et al. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir. 2002;144:703–12; discussion 12–3.
Asplund K, Israelsson K, Schampi I. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev. 2000;8:CD000103.
Allport LE, Parsons MW, Butcher KS, et al. Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology. 2005;65:1382–7.
Macdonald RL. Cerebral vasospasm. Neurosurg Q. 1995;5:73–97.
Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982;11:337–43.
Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery. 1999;44:1113–6.
Rosenwasser RH, Jallo JI, Getch CC, Liebman KE. Complications of swan-Ganz catheterization for hemodynamic monitoring in patients with subarachnoid hemorrhage. Neurosurgery. 1995;37:872–5; discussion 5–6.
Mechanical and pharmocologic treatment of vasospasm. AJNR Am J Neuroradiol. 2001;22:26S–7.
Zubkov AY, Lewis AI, Scalzo D, Bernanke DH, Harkey HL. Morphological changes after percutaneous transluminal angioplasty. Surg Neurol. 1999;51:399–403.
Bejjani GK, Bank WO, Olan WJ, Sekhar LN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1998;42:979–86; discussion 86–7.
Fujii Y, Takahashi A, Yoshimoto T. Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev. 1995;18:7–13.
Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery. 1999;44:975–9; discussion 9–80.
Eskridge JM, Newell DW, Winn HR. Endovascular treatment of vasospasm. Neurosurg Clin N Am. 1994;5:437–47.
Murayama Y, Song JK, Uda K, et al. Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm. AJNR Am J Neuroradiol. 2003;24:133–9.
Le Roux PD, Newell DW, Eskridge J, Mayberg MR, Winn HR. Severe symptomatic vasospasm: the role of immediate postoperative angioplasty. J Neurosurg. 1994;80:224–9.
Jabbour P, Veznedaroglu E, Liebman K, Rosenwasser RH. Is radiographic ischemia a contraindication for angioplasty in subarachnoid hemorrhage? AANS annual meeting. San Francisco: American Association of Neurological Surgeons; 2006.
Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST. The prophylactic use of transluminal balloon angioplasty in patients with fisher grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg. 1999;91:51–8.
Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol. 2004;25:819–26.
Biondi A, Ricciardi GK, Puybasset L, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol. 2004;25:1067–76.
Feng L, Fitzsimmons B-F, Young WL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol. 2002;23:1284–90.
Stuart RMMD, Helbok RMD, Kurtz PMD, et al. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery. 2011;68:337–45.
Vajkoczy P, Horn P, Bauhuf C, et al. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke. 2001;32:498–505.
McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR. Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg. 1995;83:430–4.
Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF. Intra-arterial papaverine-induced seizures: case report and review of the literature. Surg Neurol. 2001;56:159–63.
Barr JD, Mathis JM, Horton JA. Transient severe brain stem depression during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol. 1994;15:719–23.
Stiefel MF, Spiotta AM, Udoetuk JD, et al. Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen. Neurocrit Care. 2006;4:113–8.
Smith WS, Dowd CF, Johnston SC, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:2518–22.
Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 1998;88:277–84.
Fathi AR, Pluta RM, Bakhtian KD, Qi M, Lonser RR. Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates. J Neurosurg. 2011.
Fathi AR, Marbacher S, Graupner T, et al. Continuous intrathecal glyceryl trinitrate prevents delayed cerebral vasospasm in the single-SAH rabbit model in vivo. Acta Neurochir. 2011;153:1669–75; discussion 75.
Qahwash OM, Alaraj A, Aletich V, Charbel FT, Amin-Hanjani S. Safety of early endovascular catheterization and intervention through extracranial-intracranial bypass grafts. J Neurosurg. 2012;116(1):201–7.
Natarajan SK, Hauck EF, Hopkins LN, Levy EI, Siddiqui AH. Endovascular management of symptomatic spasm of radial artery bypass graft: technical case report. Neurosurgery. 2010;67:794–8; discussion 8.
Ghani GA, Sung YF, Weinstein MS, Tindall GT, Fleischer AS. Effects of intravenous nitroglycerin on the intracranial pressure and volume pressure response. J Neurosurg. 1983;58:562–5.
Molyneux AJ, Kerr RS, Birks J, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the international subarachnoid aneurysm trial (ISAT): long-term follow-up. Lancet Neurol. 2009;8:427–33.
Scott RBP, Eccles FD, Molyneux AJM, Kerr RSCMS, Rothwell PMF, Carpenter KDP. Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: neuropsychological outcomes from the international subarachnoid aneurysm trial (ISAT). Stroke. 2010;41:1743–7.
Harbaugh RE, Heros RC, Hadley MN. More on ISAT. Lancet. 2003;361:783–4; author reply 4.
McDougall CG, Spetzler RF, Zabramski JM, et al. The barrow ruptured aneurysm trial. J Neurosurg. 2012;116:135–44.
Spetzler RF, McDougall CG, Zabramski JM, et al. The barrow ruptured aneurysm trial: 6-year results. J Neurosurg. 2015;123:609–17.
Darsaut TE, Raymond J. Barrow ruptured aneurysm trial. J Neurosurg. 2012;117:378–9; author reply 9–80.
Molyneux A, Kerr R, Birks J. Barrow ruptured aneurysm trial. J Neurosurg. 2013;119:139–41.
Lanzino G. The barrow ruptured aneurysm trial. J Neurosurg. 2012;116:133–4; discussion 4.
Harrison L. Clipping has advantages over coiling for ruptured aneurysms. Medscape: Medscape Medical News; 2014.
Huang J, McGirt MJ, Gailloud P, Tamargo RJ. Intracranial aneurysms in the pediatric population: case series and literature review. Surg Neurol. 2005;63:424–32; discussion 32–3.
Fulkerson DH, Voorhies JM, Payner TD, et al. Middle cerebral artery aneurysms in children: case series and review. J Neurosurg. 2011;8:79–89.
Sanai N, Quinones-Hinojosa A, Gupta NM, et al. Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management. J Neurosurg. 2006;104:82–9.
Laughlin S, terBrugge KG, Willinsky RA, Armstrong DC, Montanera WJ, Humphreys RP. Endovascular management of paediatric intracranial aneurysms. Interv Neuroradiol. 1997;3:205–14.
Khoo LT, Levy ML. Intracerebral aneurysms. In: Albright AL, Pollack IF, Adelson PD, editors. Principles and practice of pediatric neurosurgery. New York: Thieme Medical Publishers; 1999.
Kanaan I, Lasjaunias P, Coates R. The spectrum of intracranial aneurysms in pediatrics. Minim Invasive Neurosurg. 1995;38:1–9.
Buis DR, van Ouwerkerk WJ, Takahata H, Vandertop WP. Intracranial aneurysms in children under 1 year of age: a systematic review of the literature. Childs Nerv Syst. 2006.
Saini S, Speller-Brown B, Wyse E, et al. Unruptured intracranial aneurysms in children with sickle cell disease: analysis of 18 aneurysms in 5 patients. Neurosurgery. 2015;76:531–8; discission 8–9; quiz 9.
Batnitzky S, Muller J. Infantile and juvenile cerebral aneurysms. Neuroradiology. 1978;16:61–4.
Aryan HE, Giannotta SL, Fukushima T, Park MS, Ozgur BM, Levy ML. Aneurysms in children: review of 15 years experience. J Clin Neurosci. 2006;13:188–92.
Ventureyra EC, Higgins MJ. Traumatic intracranial aneurysms in childhood and adolescence. Case reports and review of the literature. Childs Nerv Syst. 1994;10:361–79.
Ostergaard JR, Voldby B. Intracranial arterial aneurysms in children and adolescents. J Neurosurg. 1983;58:832–7.
Moftakhar P, Cooke DL, Fullerton HJ, et al. Extent of collateralization predicting symptomatic cerebral vasospasm among pediatric patients: correlations among angiography, transcranial Doppler ultrasonography, and clinical findings. J Neurosurg Pediatr. 2015;15:282–90.
Lasjaunias P, Wuppalapati S, Alvarez H, Rodesch G, Ozanne A. Intracranial aneurysms in children aged under 15 years: review of 59 consecutive children with 75 aneurysms. Childs Nerv Syst. 2005;21:437–50.
Kakarla UK, Beres EJ, Ponce FA, et al. Microsurgical treatment of pediatric intracranial aneurysms: long-term angiographic and clinical outcomes. Neurosurgery. 2010;67:237–49; discussion 50.
Koroknay-Pal P, Niemela M, Lehto H, et al. De novo and recurrent aneurysms in pediatric patients with cerebral aneurysms. Stroke. 2013;44:1436–9.
Sawin P. Spontaneous subarachnoid hemorrhage in pregnancy and the puerperium. In: Loftus C, editor. Neurosurgical aspects of pregnancy. Park Ridge, IL: American Association of Neurological Surgeons; 1996. p. 85–99.
Wiebers DO. Subarachnoid hemorrhage in pregnancy. Semin Neurol. 1988;8:226–9.
Measurements NCoRPa, ed. Recommendations on limits for exposure to ionizing radiation (NCRP report no. 91). National Council on Radiation Protection: Bethesda, MD; 1987.
Piper J. Fetal toxicity of common neurosurgical drugs. In: Loftus C, editor. Neurosurgical aspects of pregnancy. Park Ridge, IL: American Association of Neurological Surgeons; 1996. p. 1–20.
Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery. 1990;27:855–65; discussion 65–6.
Verweij RD, Wijdicks EF, van Gijn J. Warning headache in aneurysmal subarachnoid hemorrhage. A case-control study. Arch Neurol. 1988;45:1019–20.
Lennon RL, Sundt TM Jr, Gronert GA. Combined cesarean section and clipping of intracerebral aneurysm. Anesthesiology. 1984;60:240–2.
Meyers PM, Halbach VV, Malek AM, et al. Endovascular treatment of cerebral artery aneurysms during pregnancy: report of three cases. AJNR Am J Neuroradiol. 2000;21:1306–11.
Piotin M, de Souza Filho CB, Kothimbakam R, Moret J. Endovascular treatment of acutely ruptured intracranial aneurysms in pregnancy. Am J Obstet Gynecol. 2001;185:1261–2.
Kizilkilic O, Albayram S, Adaletli I, et al. Endovascular treatment of ruptured intracranial aneurysms during pregnancy: report of three cases. Arch Gynecol Obstet. 2003;268:325–8.
Robinson JL, Hall CJ, Sedzimir CB. Subarachnoid hemorrhage in pregnancy. J Neurosurg. 1972;36:27–33.
Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium. A study of 135 patients. Angiology. 1983;34:731–46.
Heikkinen JE, Rinne RI, Alahuhta SM, et al. Life support for 10 weeks with successful fetal outcome after fatal maternal brain damage. Br Med J (Clin Res Ed). 1985;290:1237–8.
Stolz-Born G, Widder B, Born J. Vascular effects of oxytocin on human middle cerebral artery determined by transcranial Doppler sonography. Regul Pept. 1996;62:37–9.
Barker FG 2nd, Amin-Hanjani S, Butler WE, et al. Age-dependent differences in short-term outcome after surgical or endovascular treatment of unruptured intracranial aneurysms in the United States, 1996–2000. Neurosurgery. 2004;54:18–28; discussion -30.
Khanna RK, Malik GM, Qureshi N. Predicting outcome following surgical treatment of unruptured intracranial aneurysms: a proposed grading system. J Neurosurg. 1996;84:49–54.
Chung RY, Carter BS, Norbash A, Budzik R, Putnam C, Ogilvy CS. Management outcomes for ruptured and unruptured aneurysms in the elderly. Neurosurgery. 2000;47:827–32; discussion 32–3.
Bradac GB, Bergui M, Fontanella M. Endovascular treatment of cerebral aneurysms in elderly patients. Neuroradiology. 2005;47:938–41.
Cai Y, Spelle L, Wang H, et al. Endovascular treatment of intracranial aneurysms in the elderly: single-center experience in 63 consecutive patients. Neurosurgery. 2005;57:1096–102; discussion -102.
Inagawa T. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980–1989 and 1990–1998. Stroke. 2001;32:1499–507.
Shimamura N, Munakata A, Ohkuma H. Current management of subarachnoid hemorrhage in advanced age. Acta Neurochir Suppl. 2011;110:151–5.
Sedat J, Dib M, Lonjon M, et al. Endovascular treatment of ruptured intracranial aneurysms in patients aged 65 years and older: follow-up of 52 patients after 1 year. Stroke. 2002;33:2620–5.
Nieuwkamp DJ, GJE R, Silva R, Greebe P, Schokking DA, Ferro JM. Subarachnoid haemorrhage in patients older than 75 years: clinical course, treatment and outcome. J Neurol Neurosurg Psychiatry. 2006;77(8):933–7.
Lan Q, Ikeda H, Jimbo H, Izumiyama H, Matsumoto K. Considerations on surgical treatment for elderly patients with intracranial aneurysms. Surg Neurol. 2000;53:231–8.
Ferch R, Pasqualin A, Barone G, Pinna G, Bricolo A. Surgical management of ruptured aneurysms in the eighth and ninth decades. Acta Neurochir. 2003;145:439–45; discussion 45.
Jain R, Deveikis J, Thompson BG. Endovascular management of poor-grade aneurysmal subarachnoid hemorrhage in the geriatric population. AJNR Am J Neuroradiol. 2004;25:596–600.
Church W. Aneurysm of the right cerebral artery in a boy of thirteen. Trans Pathol Soc Lond. 1869;20:109.
Osler W. Gulstonian lectures on malignant endocarditis. Lancet. 1885;1:415–8, 505–8.
Clare CE, Barrow DL. Infectious intracranial aneurysms. Neurosurg Clin N Am. 1992;3:551–66.
Chun JY, Smith W, Halbach VV, Higashida RT, Wilson CB, Lawton MT. Current multimodality management of infectious intracranial aneurysms. Neurosurgery. 2001;48:1203–13; discussion 13–4.
Bohmfalk GL, Story JL, Wissinger JP, Brown WE Jr. Bacterial intracranial aneurysm. J Neurosurg. 1978;48:369–82.
Phuong LK, Link M, Wijdicks E. Management of intracranial infectious aneurysms: a series of 16 cases. Neurosurgery. 2002;51:1145–51; discussion 51–2.
Yao KC, Bederson JB. Infectious intracranial aneurysms. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 2101–6.
Ojemann RG. Surgical management of bacterial intracranial aneurysms. In: Schmidek HH, Sweet WH, editors. Operative neurosurgical techniques. New York: Grune & Stratton; 1988. p. 997–1001.
Kojima Y, Saito A, Kim I. The role of serial angiography in the management of bacterial and fungal intracranial aneurysms—report of two cases and review of the literature. Neurol Med Chir (Tokyo). 1989;29:202–16.
Molinari GF, Smith L, Goldstein MN, Satran R. Pathogenesis of cerebral mycotic aneurysms. Neurology. 1973;23:325–32.
Hurst RW, Judkins A, Bolger W, Chu A, Loevner LA. Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation. AJNR Am J Neuroradiol. 2001;22:858–63.
Morawetz RB, Karp RB. Evolution and resolution of intracranial bacterial (mycotic) aneurysms. Neurosurgery. 1984;15:43–9.
Barrow DL, Prats AR. Infectious intracranial aneurysms: comparison of groups with and without endocarditis. Neurosurgery. 1990;27:562–72; discussion 72–3.
Petr O, Brinjikji W, Burrows AM, Cloft H, Kallmes DF, Lanzino G. Safety and efficacy of endovascular treatment for intracranial infectious aneurysms: a systematic review and meta-analysis. J Neuroradiol. 2016;43:309–16.
Rout D, Sharma A, Mohan PK, Rao VR. Bacterial aneurysms of the intracavernous carotid artery. J Neurosurg. 1984;60:1236–42.
Hutchinson J. Aneurysms of the internal carotid within the skull diagnosed 11 years before the patient's death: spontaneous cure. Trans Clin Soc (Lond). 1987;8:127.
Choi IS, David C. Giant intracranial aneurysms: development, clinical presentation and treatment. Eur J Radiol. 2003;46:178–94.
Koyama S, Kotani A, Sasaki J. Giant basilar artery aneurysm with intramural hemorrhage and then disastrous hemorrhage: case report. Neurosurgery. 1996;39:174–7; discussion 7–8.
Nagahiro S, Takada A, Goto S, Kai Y, Ushio Y. Thrombosed growing giant aneurysms of the vertebral artery: growth mechanism and management. J Neurosurg. 1995;82:796–801.
Lawton MT, Spetzler RF. Surgical strategies for giant intracranial aneurysms. Neurosurg Clin N Am. 1998;9:725–42.
Lemole GM Jr, Henn JS, Spetzler RF, Riina HA. Giant aneurysms. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 2079–99.
Gruber A, Killer M, Bavinzski G, Richling B. Clinical and angiographic results of endosaccular coiling treatment of giant and very large intracranial aneurysms: a 7-year, single-center experience. Neurosurgery. 1999;45:793–803; discussion -4.
Drake CG, Peerless SJ. Giant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1965 to 1992. J Neurosurg. 1997;87:141–62.
Dengler J, Maldaner N, Bijlenga P, et al. Perianeurysmal edema in giant intracranial aneurysms in relation to aneurysm location, size, and partial thrombosis. J Neurosurg. 2015;123:446–52.
Raymond LA, Tew J. Large suprasellar aneurysms imitating pituitary tumour. J Neurol Neurosurg Psychiatry. 1978;41:83–7.
Bokemeyer C, Frank B, Brandis A, Weinrich W. Giant aneurysm causing frontal lobe syndrome. J Neurol. 1990;237:47–50.
Lownie SP, Drake CG, Peerless SJ, Ferguson GG, Pelz DM. Clinical presentation and management of giant anterior communicating artery region aneurysms. J Neurosurg. 2000;92:267–77.
Michael WF. Posterior fossa aneurysms simulating tumours. J Neurol Neurosurg Psychiatry. 1974;37:218–23.
Kodama N, Suzuki J. Surgical treatment of giant aneurysms. Neurosurg Rev. 1982;5:155–60.
Barrow DL, Alleyne C. Natural history of giant intracranial aneurysms and indications for intervention. Clin Neurosurg. 1995;42:214–44.
Elhammady MSMD, Wolfe SQMD, Farhat HMD, Ali Aziz-Sultan MMD, Heros RCMD. Carotid artery sacrifice for unclippable and uncoilable aneurysms: endovascular occlusion vs common carotid artery ligation. Neurosurgery. 2010;67:1431–7.
Gobin YP, Vinuela F, Gurian JH, et al. Treatment of large and giant fusiform intracranial aneurysms with Guglielmi detachable coils. J Neurosurg. 1996;84:55–62.
Otsuka G, Miyachi S, Handa T, et al. Endovascular trapping of giant serpentine aneurysms by using Guglielmi detachable coils: successful reduction of mass effect. Report of two cases. J Neurosurg. 2001;94:836–40.
Briganti F, Cirillo S, Caranci F, Esposito F, Maiuri F. Development of “de novo” aneurysms following endovascular procedures. Neuroradiology. 2002;44:604–9.
Ross IB, Weill A, Piotin M, Moret J. Endovascular treatment of distally located giant aneurysms. Neurosurgery. 2000;47:1147–52. discussion 52–3
Malisch TW, Guglielmi G, Vinuela F, et al. Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients. J Neurosurg. 1997;87:176–83.
Higashida RT, Smith W, Gress D, et al. Intravascular stent and endovascular coil placement for a ruptured fusiform aneurysm of the basilar artery. Case report and review of the literature. J Neurosurg. 1997;87:944–9.
Islak C, Kocer N, Albayram S, Kizilkilic O, Uzma O, Cokyuksel O. Bare stent-graft technique: a new method of endoluminal vascular reconstruction for the treatment of giant and fusiform aneurysms. AJNR Am J Neuroradiol. 2002;23:1589–95.
Mizutani T. Natural course of intracranial arterial dissections. J Neurosurg. 2011;114:1037–44.
Sikkema T, Uyttenboogaart M, van Dijk JM, et al. Clinical features and prognosis of intracranial artery dissection. Neurosurgery. 2015;76:663–70; discussion 70–1.
Yamaura A, Ono J, Hirai S. Clinical picture of intracranial non-traumatic dissecting aneurysm. Neuropathology. 2000;20:85–90.
Kurino M, Yoshioka S, Ushio Y. Spontaneous dissecting aneurysms of anterior and middle cerebral artery associated with brain infarction: a case report and review of the literature. Surg Neurol. 2002;57:428–36; discussion 36–8.
Mizutani T, Kojima H. Clinicopathological features of non-atherosclerotic cerebral arterial trunk aneurysms. Neuropathology. 2000;20:91–7.
Okuchi K, Watabe Y, Hiramatsu K, et al. Dissecting aneurysm of the vertebral artery as a cause of Wallenberg's syndrome (in Japanese with English abstract). No Shinkei Geka. 1990;18:721–7.
Ojemann RG, Fisher CM, Rich JC. Spontaneous dissecting aneurysm of the internal carotid artery. Stroke. 1972;3:434–40.
Bhattacharya RN, Menon G, Nair S. Dissecting intracranial vertebral artery aneurysms. Neurol India. 2001;49:391–4.
Nagahiro S, Hamada J, Sakamoto Y, Ushio Y. Follow-up evaluation of dissecting aneurysms of the vertebrobasilar circulation by using gadolinium-enhanced magnetic resonance imaging. J Neurosurg. 1997;87:385–90.
Sasaki O, Ogawa H, Koike T, Koizumi T, Tanaka R. A clinicopathological study of dissecting aneurysms of the intracranial vertebral artery. J Neurosurg. 1991;75:874–82.
Clower BR, Sullivan DM, Smith RR. Intracranial vessels lack vasa vasorum. J Neurosurg. 1984;61:44–8.
Ro A, Kageyama N. Pathomorphometry of ruptured intracranial vertebral arterial dissection: adventitial rupture, dilated lesion, intimal tear, and medial defect. J Neurosurg. 2013;119:221–7.
Mizutani T, Aruga T, Kirino T, Miki Y, Saito I, Tsuchida T. Recurrent subarachnoid hemorrhage from untreated ruptured vertebrobasilar dissecting aneurysms. Neurosurgery. 1995;36:905–11; discussion 12–3.
Yuki I, Murayama Y, Vinuela F. Endovascular management of dissecting vertebrobasilar artery aneurysms in patients presenting with acute subarachnoid hemorrhage. J Neurosurg. 2005;103:649–55.
Benndorf G, Herbon U, Sollmann WP, Campi A. Treatment of a ruptured dissecting vertebral artery aneurysm with double stent placement: case report. AJNR Am J Neuroradiol. 2001;22:1844–8.
Chiaradio JC, Guzman L, Padilla L, Chiaradio MP. Intravascular graft stent treatment of a ruptured fusiform dissecting aneurysm of the intracranial vertebral artery: technical case report. Neurosurgery. 2002;50:213–6; discussion 6–7.
Narata AP, Yilmaz H, Schaller K, Lovblad KO, Pereira VM. Flow-diverting stent for ruptured intracranial dissecting aneurysm of vertebral artery. Neurosurgery. 2012;70:982–8; discussion 8–9.
Madaelil TP, Wallace AN, Chatterjee AN, et al. Endovascular parent vessel sacrifice in ruptured dissecting vertebral and posterior inferior cerebellar artery aneurysms: clinical outcomes and review of the literature. J Neurointerv Surg. 2016;8:796–801.
Segal HD, McLaurin RL. Giant serpentine aneurysm. Report of two cases. J Neurosurg. 1977;46:115–20.
Anson JA, Lawton MT, Spetzler RF. Characteristics and surgical treatment of dolichoectatic and fusiform aneurysms. J Neurosurg. 1996;84:185–93.
Flemming KD, Wiebers DO, Brown RD Jr, et al. Prospective risk of hemorrhage in patients with vertebrobasilar nonsaccular intracranial aneurysm. J Neurosurg. 2004;101:82–7.
Pico F, Labreuche J, Hauw JJ, Seilhean D, Duyckaerts C, Amarenco P. Coronary and basilar artery ectasia are associated: results from an autopsy case-control study. Stroke. 2016;47:224–7.
Nasr DM, Brinjikji W, Rouchaud A, Kadirvel R, Flemming KD, Kallmes DF. Imaging characteristics of growing and ruptured vertebrobasilar non-saccular and dolichoectatic aneurysms. Stroke. 2016;47:106–12.
Suzuki S, Takahashi T, Ohkuma H, Shimizu T, Fujita S. Management of giant serpentine aneurysms of the middle cerebral artery—review of literature and report of a case successfully treated by STA-MCA anastomosis only. Acta Neurochir. 1992;117:23–9.
Flemming KD, Wiebers DO, Brown RD Jr, et al. The natural history of radiographically defined vertebrobasilar nonsaccular intracranial aneurysms. Cerebrovasc Dis. 2005;20:270–9.
Resta M, Gentile MA, Di Cuonzo F, Vinjau E, Brindicci D, Carella A. Clinical-angiographic correlations in 132 patients with megadolichovertebrobasilar anomaly. Neuroradiology. 1984;26:213–6.
Nishizaki T, Tamaki N, Takeda N, Shirakuni T, Kondoh T, Matsumoto S. Dolichoectatic basilar artery: a review of 23 cases. Stroke. 1986;17:1277–81.
Nakatomi H, Segawa H, Kurata A, et al. Clinicopathological study of intracranial fusiform and dolichoectatic aneurysms: insight on the mechanism of growth. Stroke. 2000;31:896–900.
Caplan LR, Baquis GD, Pessin MS, et al. Dissection of the intracranial vertebral artery. Neurology. 1988;38:868–77.
Yu YL, Moseley IF, Pullicino P, McDonald WI. The clinical picture of ectasia of the intracerebral arteries. J Neurol Neurosurg Psychiatry. 1982;45:29–36.
Mizutani T, Aruga T. “Dolichoectatic” intracranial vertebrobasilar dissecting aneurysm. Neurosurgery. 1992;31:765–73; discussion 73.
Sacks JG, Lindenburg R. Dolicho-ectatic intracranial arteries: symptomatology and pathogenesis of arterial elongation and distention. Johns Hopkins Med J. 1969;125:95–106.
Hegedus K. Ectasia of the basilar artery with special reference to possible pathogenesis. Surg Neurol. 1985;24:463–9.
Ubogu EE, Zaidat OO. Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: a cohort study. J Neurol Neurosurg Psychiatry. 2004;75:22–6.
Sacho RH, Saliou G, Kostynskyy A, et al. Natural history and outcome after treatment of unruptured intradural fusiform aneurysms. Stroke. 2014;45:3251–6.
Mawad ME, Klucznik RP. Giant serpentine aneurysms: radiographic features and endovascular treatment. AJNR Am J Neuroradiol. 1995;16:1053–60.
Benoit BG, Wortzman G. Traumatic cerebral aneurysms. Clinical features and natural history. J Neurol Neurosurg Psychiatry. 1973;36:127–38.
Parkinson D, West M. Traumatic intracranial aneurysms. J Neurosurg. 1980;52:11–20.
Fleischer AS, Patton JM, Tindall GT. Cerebral aneurysms of traumatic origin. Surg Neurol. 1975;4:233–9.
Uzan M, Cantasdemir M, Seckin MS, et al. Traumatic intracranial carotid tree aneurysms. Neurosurgery. 1998;43:1314–20; discussion 20–2.
Aarabi B. Management of traumatic aneurysms caused by high-velocity missile head wounds. Neurosurg Clin N Am. 1995;6:775–97.
Steinmetz H, Heiss E, Mironov A. Traumatic giant aneurysms of the intracranial carotid artery presenting long after head injury. Surg Neurol. 1988;30:305–10.
Nishioka T, Maeda Y, Tomogane Y, Nakano A, Arita N. Unexpected delayed rupture of the vertebral-posterior inferior cerebellar artery aneurysms following closed head injury. Acta Neurochir. 2002;144:839–45; discussion 45.
Buckingham MJ, Crone KR, Ball WS, Tomsick TA, Berger TS, Tew JM Jr. Traumatic intracranial aneurysms in childhood: two cases and a review of the literature. Neurosurgery. 1988;22:398–408.
Resnick DK, Subach BR, Marion DW. The significance of carotid canal involvement in basilar cranial fracture. Neurosurgery. 1997;40:1177–81.
Haddad FS, Haddad GF, Taha J. Traumatic intracranial aneurysms caused by missiles: their presentation and management. Neurosurgery. 1991;28:1–7.
Holmes B, Harbaugh RE. Traumatic intracranial aneurysms: a contemporary review. J Trauma. 1993;35:855–60.
Luo C-B, Teng MM-H, Chang F-C, Lirng J-F, Chang C-Y. Endovascular management of the traumatic cerebral aneurysms associated with traumatic carotid cavernous fistulas. AJNR Am J Neuroradiol. 2004;25:501–5.
Horowitz MB, Kopitnik TA, Landreneau F, et al. Multidisciplinary approach to traumatic intracranial aneurysms secondary to shotgun and handgun wounds. Surg Neurol. 1999;51:31–42.
Kakarieka A, Braakman R, Schakel EH. Clinical significance of the finding of subarachnoid blood on CT scan after head injury. Acta Neurochir. 1994;129:1–5.
Mattioli C, Beretta L, Gerevini S, et al. Traumatic subarachnoid hemorrhage on the computerized tomography scan obtained at admission: a multicenter assessment of the accuracy of diagnosis and the potential impact on patient outcome. J Neurosurg. 2003;98:37–42.
Servadei F, Murray GD, Teasdale GM, et al. Traumatic subarachnoid hemorrhage: demographic and clinical study of 750 patients from the European brain injury consortium survey of head injuries. Neurosurgery. 2002;50:261–7; discussion 7–9.
Gomez PA, Lobato RD, Ortega JM, De La Cruz J. Mild head injury: differences in prognosis among patients with a Glasgow coma scale score of 13 to 15 and analysis of factors associated with abnormal CT findings. Br J Neurosurg. 1996;10:453–60.
Shackford SR, Wald SL, Ross SE, et al. The clinical utility of computed tomographic scanning and neurologic examination in the management of patients with minor head injuries. J Trauma. 1992;33:385–94.
Oertel M, Boscardin WJ, Obrist WD, et al. Posttraumatic vasospasm: the epidemiology, severity, and time course of an underestimated phenomenon: a prospective study performed in 299 patients. J Neurosurg. 2005;103:812–24.
Macmillan CS, Wild JM, Wardlaw JM, Andrews PJ, Marshall I, Easton VJ. Traumatic brain injury and subarachnoid hemorrhage: in vivo occult pathology demonstrated by magnetic resonance spectroscopy may not be “ischaemic”. A primary study and review of the literature. Acta Neurochir. 2002;144:853–62; discussion 62.
Langham J, Goldfrad C, Teasdale G, Shaw D, Rowan K. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev. 2003;4:CD000565.
Cairns CJ, Finfer SR, Harrington TJ, Cook R. Papaverine angioplasty to treat cerebral vasospasm following traumatic subarachnoid haemorrhage. Anaesth Intensive Care. 2003;31:87–91.
Roy D, Raymond J, Bouthillier A, Bojanowski MW, Moumdjian R, L'Esperance G. Endovascular treatment of ophthalmic segment aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol. 1997;18:1207–15.
Mascitelli JR, Moyle H, Oermann EK, et al. An update to the Raymond-Roy occlusion classification of intracranial aneurysms treated with coil embolization. J Neurointerv Surg. 2015;7:496–502.
Meyers PM, Schumacher HC, Higashida RT, et al. Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. J NeuroIntervent Surg. 2010;2:312–23.
O'Kelly CJ, Krings T, Fiorella D, Marotta TR. A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents. Interv Neuroradiol. 2010;16:133–7.
Arias E, Heron M, Xu J. United States Life Tables, 2012. Natl Vital Stat Rep. 2012;65:1–38.
Kondziolka D, McLaughlin MR, Kestle JR. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery. 1995;37:851–5.
Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.
Hijdra A, Brouwers PJ, Vermeulen M, van Gijn J. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke. 1990;21:1156–61.
Suarez JI, Zaidat OO, Suri MF, et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med. 2004;32:2311–7.
Finn SS, Stephensen SA, Miller CA, Drobnich L, Hunt WE. Observations on the perioperative management of aneurysmal subarachnoid hemorrhage. J Neurosurg. 1986;65:48–62.
Kasuya H, Kawashima A, Namiki K, Shimizu T, Takakura K. Metabolic profiles of patients with subarachnoid hemorrhage treated by early surgery. Neurosurgery. 1998;42:1268–74; discussion 74–5.
Suarez JI, Shannon L, Zaidat OO, et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg. 2004;100:585–90.
Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619–24.
Mee E, Dorrance D, Lowe D, Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery. 1988;22:484–91.
Ohman J, Heiskanen O. Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg. 1988;69:683–6.
Petruk KC, West M, Mohr G, et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988;68:505–17.
Flemming KD, Brown RD Jr, Wiebers DO. Subarachnoid hemorrhage. Curr Treat Options Neurol. 1999;1:97–112.
Black PM, Crowell RM, Abbott WM. External pneumatic calf compression reduces deep venous thrombosis in patients with ruptured intracranial aneurysms. Neurosurgery. 1986;18:25–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Harrigan, M.R., Deveikis, J.P. (2018). Intracranial Aneurysms and Subarachnoid Hemorrhage. In: Handbook of Cerebrovascular Disease and Neurointerventional Technique. Contemporary Medical Imaging. Humana, Cham. https://doi.org/10.1007/978-3-319-66779-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-66779-9_12
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-319-66777-5
Online ISBN: 978-3-319-66779-9
eBook Packages: MedicineMedicine (R0)